ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS

/ SCIENCE, SOLUTIONS / By

  1. -drug interaction potential of 1, 5-dicaffeylquinic acid, a new herbal drug for the treatment of hepatitis B and human immunodeficiency virus
  2. 
 -enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration
  3. 
 -inhibitory protein 1α, and the eosinophil product major basic protein are released into upper respiratory secretions during virus -induced asthma exacerbations in 

  4. 
 , a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri
  5. 
 , and therapeutic targets of antiviral agents: Focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral 

  6. 
 , polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and 

  7. 
 ) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-ÎșB–dependent induction of antiviral 

  8. 
 [3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia virus 

  9. 
 a bacterial cholesterol dehydrogenase, a bacterial UDP‐galactose‐4‐epimerase, and open reading frames in vaccinia virus and fish lymphocystis disease virus
  10. 
 A virus Subtypes H1N1, H1N2 and H3N2, HDFx: A Novel Immunomodulator and Potential Fighter Against cytokine Storms in viral Flu Infections-Carica 

  11. 
 acid isolated from Laggera pterodonta suppressed RIG-I/NF-KB/STAT1/Type I interferon and programmed death-ligand 1/2 activation induced by influenza A virus in 

  12. 
 and biological evaluation of the compounds of Justicia gendarussa leaves extract as interferon gamma inducer: a study of anti Human immunodeficiency virus (HIV) 

  13. 
 and Functional Diversity of the 5â€Č Untranslated Region of Enterovirus D68: Increased Activity of the Internal Ribosome Entry Site of viral Strains during the 2010s
  14. 
 and identification of Naphthoquinones from Euclea natalensis with activity against Mycobacterium tubercolosis, other pathogenic bacteria and Herpes simplex virus
  15. 
 antiviral action of a polyphenolic complex isolated from the medicinal plant Geranium sanguineum L. VIII. Inhibitory effect on the reproduction of herpes simplex virus 

  16. 
 APPROACH ON UNDERSTANDING STRUCTURAL INTERACTIONS OF ENVELOPE PROTEIN OF DENGUE virus BOUND WITH SQUALENE, A 

  17. 
 azido-reductase in human liver microsomes: activation by ethacrynic acid, dipyridamole, and indomethacin and inhibition by human immunodeficiency virus protease 

  18. 
 B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral 

  19. 
 Characterization of a Polysaccharide Fraction from Platycladus orientalis (L.) Franco and Its Macrophage immunomodulatory and Anti-Hepatitis B virus Activities
  20. 
 Chemical Composition of extract s from Ageratina havanensis Collected in Two Different Phenological Stages by FIA-ESI-IT-MSn and UPLC/ESI-MSn: antiviral 

  21. 
 CYP1A1 gene by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin but not by ÎČ-naphthoflavone or 3-methylcholanthrene is altered in hepatitis C virus replicon-expressing cells
  22. 
 et Gilg Using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and Preliminary Screening for Anti-Influenza virus 

  23. 
 FOR IDENTIFICATION OF PROMISING ANTIMICROBIALS OF herbal ORIGIN AGAINST HIGHLY VIRULENT STRAINS OF INFLUENZA virus
  24. 
 Fractions of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) extract Inhibit Neuraminidase Activity in Newcastle Disease virus 

  25. 
 from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-ÎșB p65 signal pathway and protects mice from CVB3-induced virus 

  26. 
 herb extract s ameliorate impaired growth performance and intestinal lesion of newborn piglets challenged with the virulent porcine epidemic diarrhea virus
  27. 
 inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson’s disease induced by Japanese encephalitis virus
  28. 
 investigations on the response capacities of Guinean traditional health practioners in the management of outbreaks of infectious diseases: The case of the Ebola virus 

  29. 
 marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral 

  30. 
 molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus
  31. 
 novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease
  32. 
 of 3-C-Hydroxymethyl-substituted Pyrimidine and Purine Nucleosides as Potential Anti-Hepatitis Cand Purine Nucleosides as Potential Anti-Hepatitis C virus 

  33. 
 of Ag nanostructures using the seed extract of Pedalium murex, an ancient Indian medicinal plant : histopathological effects on the Zika virus vector Aedes aegypti and 

  34. 
 of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical 

  35. 
 of Novel Hybrid Dicaffeoyltartaric/Diketo Acid and Tetrazole-Substituted l-Chicoric Acid Analogue Inhibitors of Human immunodeficiency virus Type 1 Integrase
  36. 
 of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE 

  37. 
 of seven sesquiterpene lactone glucosides in Ixeris dentata by high-performance liquid chromatography coupled with tandem mass spectrometry and their antiviral 

  38. 
 OF SICKLY CHILDREN OF GENE POLYMORPHISM (ASP299GLY) TOLL-4 AND (SER249PRO) TOLL-6 RECEPTOR WITH ACUTE RESPIRATORY viral 

  39. 
 of silver nanocomposites using the aqueous extract of Rubus ellipticus leaves: toxicity and oviposition deterrent activity against Zika virus , malaria and filariasis 

  40. 
 of zolpidem, necopidem, alpidem, saripidem, miroprofen, zolimidine, olprinone and abafungin as anti–tumor, peptide antibiotics, antiviral and central nervous 

  41. 
 on Performance, GI Microbial Population, Intestinal Morphology and Serum Lipids of Broiler Chickens Challenged with Infectious Bronchitis Vaccine virus
  42. 
 Parameters, Molecular Docking and Quantum Computations of plant Derived Compounds Exhibiting Strong Inhibitory Potential Against NS5 from Zika virus
  43. 
 plant extract s for their ovicidal, larvicidal and pupicidal activity against medically important human dengue, chikungunya and zika virus vector, Aedes aegypti 

  44. 
 report> Studies on Inhibitors of Skins Tumor Promotion XI.: Inhibitory Effects of FLAVONOIDS from Scutellaria baicalensis on Epstein-Barr virus Activation and Their Anti 

  45. 
 Sarcoma and Simian Sarcoma-Associated virus : I. Analysis of viral Structural Proteins, and Preparation and Characterization of Antiserum Specific for viral 

  46. 
 the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza A virus induced acute lung injury
  47. 
 the production of unsaturated fatty acid esters and FLAVONOIDS from date palm pollen and their effects as anti-breast-cancer and antiviral agents: An in-vitro 

  48. 
 UNDERSTANDING STRUCTURAL INTERACTIONS OF ENVELOPE PROTEIN OF DENGUE virus BOUND WITH SQUALENE, A PROTOTYPE ANTI-viral 

  49. 
 with a grape seed proanthocyanidin extract downregulates proinflammatory cytokine expression in airway epithelial cells infected with respiratory syncytial virus
  50. (+)‑pinoresinol‑O‑ÎČ‑D‑glucopyranoside from Eucommia ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza A (H1N1) virus 

  51. (−)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase
  52. (−)-Epigallocatechin gallate inhibits hepatitis C virus (HCV) viral protein NS5B
  53. (−)‐Epigallocatechin‐3‐gallate is a new inhibitor of hepatitis C virus entry
  54. (171) Blueberry Leaf Inhibits Hepatitis C virus RNA Replication
  55. 1-Cinnamoyl-3, 11-dihydroxymeliacarpin delays glycoprotein transport restraining virus multiplication without cytotoxicity
  56. 1, 4-Benzodioxane Lignans: An Efficient, Asymmetric Synthesis of Flavonolignans and Study of Neolignan Cytotoxicity and antiviral Profiles
  57. 1. Multi-target QSAR of antiviral drugs
  58. 14-Deoxy-11, 12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral 

  59. 14-Noreudesmane sesquiterpenes from leaves of Nicotiana tabacum and their antiviral activity
  60. 1839321. Infection of Avian Pox virus in Oriental Turtle-Doves
  61. 2D-and 3D-QSAR studies of flavonoids, biflavone s and chalcones: antiviral , antibacterial, antifungal, and antimycobacterial activities
  62. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase
  63. 3D-QSAR Study of 1, 4-Benzodiazepines as Inhibitors of Syncytial virus
  64. 6.0 PHYTOCHEMICAL ANALYSIS AND IN VITRO ANTI-AFRICAN SWINE FEVER virus ACTIVITY OF extract S AND FRACTIONS OF ANCISTROCLADUS 

  65. 62 EVALUATION OF antiviral ACTIVITY AND TOLERANCE OF A NOVEL SUSTAINED RELEASE INTERFERON-ALPHA-2B (IFN-ALPHA-2BXL) 

  66. 8-Prenylkaempferol suppresses influenza A virus -induced RANTES production in A549 cells via blocking PI3K-mediated transcriptional activation of NF-ÎșB and IRF3
  67. 9 Nutrition and Nonalcoholic and viral Liver Diseases
  68. A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities
  69. A [1, 10] Phenanthroline Derivative Inhibits Influenza virus Propagation Through Modulating Mitogen-Activated Protein Kinase Signaling Pathways
  70. A cell-based, microplate colorimetric screen identifies 7, 8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus
  71. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter
  72. A clinical study investigating the impact of adding silymarin to combined therapy (pegylated interferon+ ribavirin) on hepatitis C virus viremia
  73. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extract s of Chinese medicinal herbs
  74. A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial 

  75. A computational approach of antibiotics as novel drug target for Japanese encephalitis virus NS helicase/nucleoside triphosphatase
  76. A computational model for docking of noncompetitive neuraminidase inhibitors and probing their binding interactions with neuraminidase of influenza virus H5N1
  77. A dual character of FLAVONOIDS in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways
  78. A facile inhibitor screening of hepatitis C virus NS3 protein using nanoparticle-based RNA
  79. A flavonoid compound library screen revealed potent antiviral activity of plant -derived FLAVONOIDS on human enterovirus A71 replication
  80. A furoviral replicase recruits host HSP70 to membranes for viral RNA replication
  81. A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase
  82. A high-throughput virus -induced gene silencing protocol identifies genes involved in multi-stress tolerance
  83. A merged molecular docking, ADME-T and dynamics approaches towards the genus of Arisaema as herpes simplex virus type 1 and type 2 inhibitors
  84. A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds
  85. A multi-target approach for discovery of antiviral compounds against dengue virus from green tea
  86. A network flow approach to predict protein targets and flavonoid backbones to treat respiratory syncytial virus infection
  87. A new biflavonoid with antiviral activity from the roots of Wikstroemia indica
  88. A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
  89. A New Flavonol Glycoside Gallate Ester from Acer okamotoanum and Its Inhibitory Activity against Human immunodeficiency virus -1 (HIV-1) Integrase
  90. A novel flavanone derivative inhibits dengue virus fusion and infectivity
  91. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture
  92. A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease
  93. A novel viral vector-mediated RNAi of HPV16 E6 expression in human cervical cancer cell Caski
  94. A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells
  95. A plant polyphenol-rich extract restores the suppressed functions of phagocytes in influenza virus -infected mice
  96. A polyphenol rich extract from Solanum melongena L. DR2 peel exhibits antioxidant properties and anti-Herpes Simplex virus Type 1 activity in vitro
  97. A polyphenol rich plant extract , CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance
  98. A Polyphenolic extract from Geranium Sanguineum L. Inhibits Influenza virus Protein Expression
  99. A Potential Role of the Heparan Sulfate in the Hepatitis C virus Attachment
  100. A preliminary study of virus -inhibiting effect of volatile oil from Artemsia argyi [J]
  101. A proteomic analysis of the anti-dengue virus activity of andrographolide
  102. A Randomized Open Label Parallel Group Clinical Study to Evaluate the Efficacy and Safety of Clevira in Fever of viral Origin
  103. A review of ethnobotany, phytochemistry, antiviral and cytotoxic/anticancer potential of morus alba linn
  104. A review of selected bee products as potential anti-bacterial, anti-fungal, and anti-viral agents
  105. A Review of the antiviral Properties of Black Elder (Sambucus nigra L.) Products
  106. A review of the antiviral role of green tea catechins
  107. A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap?
  108. A Review on Antitumor and antiviral Potential of Cranberries (Vaccinium Vitis-Idaea) Origin from Bulgaria
  109. A review on antiviral activity of the Himalayan medicinal plant s traditionally used to treat bronchitis and related symptoms
  110. A review on recent developments of indole-containing antiviral agents
  111. A review on treatment of Human immunodeficiency virus (HIV) by Naturopathy
  112. A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus
  113. A search for anti-viral properties in Panamanian medicinal plant s.: The effects on HIV and its essential enzymes
  114. A simple method for isolation and detection of rubella virus in Vero cells
  115. A study on the antiviral action of a polyphenolic complex isolated from the medicinal plant Geranium sanguineum L. VIII. Inhibitory effect on the reproduction of herpes 

  116. A Study on the antiviral Effect of Dongfang Antivirus Capsule [J]
  117. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus
  118. A Theoretical Model to Study the Interaction of Erythro‐Noscapines with nsP3 protease of Chikungunya virus
  119. A-type proanthocyanidin s from lychee seeds and their antioxidant and antiviral activities
  120. Abalone hemocyanin blocks the entry of herpes simplex virus 1 into cells: a potential new antiviral strategy
  121. Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment
  122. Activation of Cellular Immunity in Herpes Simplex virus Type 1‐Infected Mice by the Oral Administration of Aqueous extract of Moringa oleifera Lam. Leaves
  123. Activation of cGAS-dependent antiviral responses by DNA intercalating agents
  124. Active Ingredients of Anti-influenza virus in Chinese Herbs [J]
  125. Active ingredients of anti/influenza A virus in natural medicines
  126. Activity investigation of pinostrobin towards herpes simplex virus -1 as determined by atomic force microscopy
  127. Activity of acetone and methanol extract s from thirty-one medicinal plant species against herpes simplex virus types 1 and 2
  128. Adjuvant activity of ethanol extract of Hippophae rhamnoides leaves with inactivated rabies virus antigen
  129. Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins
  130. Adjuvant effect of Vernonia amygdalina leaf extract on host immune response to hepatitis B virus subunit vaccine
  131. Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus
  132. Advances and challenges in the synthesis of highly oxidised natural phenols with antiviral , antioxidant and cytotoxic activities
  133. Advances in developing therapies to combat Zika virus : current knowledge and future perspectives
  134. Advances in structure-assisted antiviral discovery for animal viral diseases
  135. Advances in the Clinical Treatment of viral Myocarditis
  136. Advances in the development of antiviral strategies against parvovirus B19
  137. Advances in the Development of antiviral Strategies against Parvovirus B19
  138. Aeginetia indica decoction inhibits hepatitis C virus life cycle
  139. African swine fever virus AP endonuclease is a redox-sensitive enzyme that repairs alkylating and oxidative damage to DNA
  140. AIDS-antiviral natural Products Research at The US National Cancer Institute
  141. Aikeqing decreases viral loads in SHIV89.6-infected Chinese rhesus macaques
  142. alkaloids as the natural anti-influenza virus agents: a systematic review
  143. Alkylated flavanone s from the Bark of Cryptocarya chartacea As Dengue virus NS5 Polymerase Inhibitors
  144. Allosteric inhibition of the NS2B-NS3 protease from dengue virus
  145. Almond skin extract s abrogate HSV-1 replication by blocking virus binding to the cell
  146. Alpinone exhibited immunomodulatory and antiviral activities in Atlantic salmon
  147. Amaryllidaceae alkaloids inhibit nuclear‐to‐cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1
  148. Amelioration of influenza virus -induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
  149. Amentoflavone Inhibits HSV-1 and ACV-Resistant Strain Infection by Suppressing viral Early Infection
  150. An active component containing pterodontic acid and pterodondiol isolated from Laggera pterodonta inhibits influenza A virus infection through the TLR7 

  151. An anti-influenza virus activity-calibrated chemical standardization approach for quality evaluation of indigo natural is
  152. An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high‐throughput method
  153. An Assay on the antiviral Activity of Mulberry Leaf extract [J]
  154. An evaluation of the antibacterial and antiviral activities of some bryophytes
  155. An evaluation of the antioxidant and antiviral action of extract s of rosemary and Provencal herbs
  156. An examination of the medicinal potential of Planchonella queenslandica: toxicity, antibacterial, and antiviral activities
  157. An examination of the medicinal potential of Scaevola spinescens: Toxicity, antibacterial, and antiviral activities
  158. An Experimental Research on the Anti-gland virus of Gangting
  159. An Experimental Study on antiviral Activity of Juhuangshangqing Buccal Tablet [J]
  160. An extract from Taxodium distichum targets hemagglutinin-and neuraminidase-related activities of influenza virus in vitro
  161. An extract ed Fraction of Pseudomonas Oleovorans Can Inhibit viral Entry and RNA Replication of Hepatitis C virus in Cell Culture
  162. An in-silico investigation of phytochemicals as antiviral agents against dengue fever
  163. An Initial Study on Mechanism of Zhong Yan Ⅱ in antiviral Activity Against Simian immunodeficiency virus [J]
  164. An overview of antiviral RNA silencing in plant : biogenesis, host–virus interaction and potential applications
  165. An overview on Zika virus and the importance of computational drug discovery
  166. Analysis of Antigenic and Genetic Characteristics of Influenza virus B Circulated in Sichuan Province in 2007
  167. Analysis of antioxidative and antiviral biomarkers ÎČ-amyrin, ÎČ-sitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC 

  168. Analysis of antiviral and chemoprotective effects of strawberry anthocyanins
  169. Analysis of antiviral Nucleoside Utilization in Our Hospital during 2006-2010
  170. Analysis of bioactive composites and antiviral activity of Iresine herbstii extract s against Newcastle disease virus in ovo
  171. Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen‐activated protein kinase and c‐Jun‐N 

  172. Analysis of influence of baicalin joint resveratrol retention enema on the TNF-α, SIgA, IL-2, IFN-γ of rats with respiratory syncytial virus infection
  173. Analysis of secondary structure predictions of dengue virus type 2 NS2B/NS3 against crystal structure to evaluate the predictive power of the in silico methods
  174. Analysis of the antigenic and genetic characteristics of influenza virus subtype A3 circulated in Sichuan Province during 2006–2007
  175. Analysis on Epidemiological Characteristics of Influenza B virus in Shenzhen from 2009 to 2011 [J]
  176. Antagonism of baicalin on cell cyclical distribution and cell apoptosis in A549 cells infected with influenza A (H1N1) virus
  177. Anthracene-based inhibitors of dengue virus NS2B–NS3 protease
  178. Anthraquinone rich Cassia fistula pod extract induces IFIT1, antiviral protein
  179. Anti influenza virus activity of a red-fleshed potato anthocyanin
  180. Anti viral Medicinal plant s ñ ñ ‚¬ ñ€ Ɠ An Ethnobotanical Approach
  181. Anti-Coxsackie virus B diterpenes from the roots of Illicium jiadifengpi
  182. Anti-Coxsackie virus B3 Norsesquiterpenoids from the Roots of Phyllanthus emblica
  183. Anti-dengue activity of Andrographis paniculata extract s and quantification of dengue viral inhibition by SYBR green reverse transcription polymerase chain 

  184. Anti-Dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition
  185. Anti-DHAV-1 reproduction and immuno-regulatory effects of a flavonoid prescription on duck virus hepatitis
  186. Anti-enterovirus 71 activity screening of Taiwanese folk medicinal plant s and immune modulation of Ampelopsis brevipedunculata (Maxim.) Trautv against the virus
  187. Anti-equine arteritis virus activity of ethanolic extract and compounds from Origanum vulgare
  188. Anti-H1N1 virus , cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis
  189. Anti-H5N1 virus FLAVONOIDS from Capparis sinaica Veill
  190. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali
  191. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging
  192. Anti-hepatitis B virus activities of Geranium carolinianum L. extract s and identification of the active components
  193. Anti-hepatitis B virus activities of triterpenoid saponin compound from potentilla anserine L.
  194. Anti-hepatitis B virus activity of chickweed [Stellaria media (L.) Vill.] extract s in HepG2. 2.15 cells
  195. Anti-Hepatitis B virus Activity of Chlorogenic Acid and Its Related Compounds
  196. Anti-Hepatitis B virus activity of FLAVONOIDS from Marchantia convoluta
  197. Anti-hepatitis B virus activity of new pyrimidine and adenine peptide nucleic acid analogues
  198. Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim
  199. Anti-hepatitis B virus activity of wogonin in vitro and in vivo
  200. Anti-hepatitis B virus constituents from the stem bark of Streblus asper
  201. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes
  202. Anti-hepatitis B virus lignans from the root of Streblus asper
  203. Anti-Hepatitis B virus Norbisabolane Sesquiterpenoids from Phyllanthus acidus and the Establishment of Their Absolute Configurations Using Theoretical 

  204. Anti-hepatitis C virus activity of a crude extract from longan (Dimocarpus longan Lour.) leaves
  205. Anti-Hepatitis C virus Activity of Crude extract and Fractions of Entada africana in Genotype 1b Replicon Systems
  206. Anti-Hepatitis C virus Dinorditerpenes from the Roots of Flueggea virosa
  207. Anti-hepatitis C virus effect of citrus unshiu peel and its active ingredient nobiletin
  208. Anti-herpes simplex virus activities of monogalactosyl diglyceride and digalactosyl diglyceride from Clinacanthus nutans, a traditional Thai herbal medicine
  209. Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha
  210. Anti-Herpes Simplex virus and antibacterial activities of Graptopetalum paraguayense E. Walther leaf extract : a pilot study
  211. Anti-herpes simplex virus component isolated from Maclura cochinchinensis
  212. Anti-herpes simplex virus effect of an aqueous extract of propolis.
  213. Anti-Herpes Simplex virus Effect of Camellia sinesis, Echiumamoenum and Nerium oleander
  214. Anti-herpes simplex virus type 1 activity of Houttuynoid A, a flavonoid from Houttuynia cordata Thunb
  215. Anti-herpes simplex virus type 1 activity of specially selected groups of tannins
  216. Anti-herpes simplex virus type 2 activity from Rhinacanthus nasutus (Linn.) Kurz. extract s as affected by different extract ion solvents
  217. Anti-herpes simplex virus type-1 FLAVONOIDS and a new flavanone from the root of Limonium sinense
  218. Anti-herpes virus activities of Achyranthes aspera: an Indian ethnomedicine, and its triterpene acid
  219. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands
  220. Anti-herpes virus activity of silibinin, the primary active component of Silybum marianum
  221. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors
  222. Anti-human immunodeficiency virus -1 activities of pratensein and pratensein glycoside from Alhaji maurorum and its parasite Cuscuta kotchiana
  223. Anti-human immunodeficiency virus -1 constituents of the bark of Poncirus trifoliata
  224. Anti-human immunodeficiency virus -type 1 activity of constituents fromJuglans mandshurica
  225. Anti-infective potential of catechins and their derivatives against viral hepatitis
  226. Anti-Infectivity against Herpes Simplex virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Eucalyptus globulus Labill.
  227. Anti-inflammatory and antiviral effects of Glossogyne tenuifolia
  228. Anti-inflammatory, antiviral and quantitative study of quercetin-3-O-ÎČ-D-glucuronide in Polygonum perfoliatum L.
  229. Anti-influenza A virus activity of a new dihydrochalcone diglycoside isolated from the Egyptian seagrass Thalassodendron ciliatum (Forsk.) den Hartog
  230. Anti-influenza A virus activity of dendrobine and its mechanism of action
  231. Anti-influenza A virus activity of epigallocatechin gallate [J]
  232. Anti-influenza A virus mechanism of three representative compounds from Flos Trollii via TLRs signaling pathways
  233. Anti-influenza activity of Alchemilla mollis extract : Possible virucidal activity against influenza virus particles
  234. Anti-influenza activity of betulinic acid from Zizyphus jujuba on influenza A/PR/8 virus
  235. Anti-influenza Chinese herbal Medicines and A Proposed Strategy to Search for Their Active Constituents Against Ebola virus
  236. Anti-influenza effect of the major FLAVONOIDS from Salvia plebeia R.Br. via inhibition of influenza H1N1 virus neuraminidase
  237. Anti-Influenza Nutraceuticals: antiviral and Anti-Inflammatory Effects
  238. Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey
  239. Anti-Influenza viral FLAVONOIDS from Persicaria filiforme
  240. Anti-influenza virus (H1N1) effect of garlic oil in vitro
  241. Anti-Influenza virus Activities of Compounds from the Medicinal plant Bletillastriata
  242. Anti-influenza virus activities of FLAVONOIDS from the medicinal plant Elsholtzia rugulosa
  243. Anti-Influenza virus activity and constituents characterization of Paeonia delavayi extract s
  244. Anti-Influenza virus Activity and Phenolic Content of Pomegranate (Punica granatum L.) Peel extract and Fractions
  245. Anti-Influenza virus Activity of Adlay Tea Components
  246. Anti-influenza virus activity of biflavonoids
  247. Anti-influenza virus activity of Ginkgo biloba leaf extract s
  248. Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
  249. Anti-Influenza virus Activity of plant Flavonoid, 5, 7, 4′-Trihydroxy-8-methoxyflavone , from the Roots of Scutellaria baicalensis and Enhancement of Its Activity by Drug 

  250. Anti-influenza virus activity of the ethanolic extract from Peperomia sui
  251. Anti-influenza virus Effect of Kening Granule [J]
  252. Anti-influenza virus effects of catechins: A molecular and clinical review
  253. Anti-influenza virus effects of elderberry juice and its fractions
  254. Anti-influenza virus effects of elderberry juice and its fractions
  255. Anti-influenza virus effects of the aqueous extract from Mosla scabra
  256. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
  257. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics
  258. Anti-Mayaro virus activity of Cassia australis extract s (Fabaceae, Leguminosae)
  259. Anti-mumps virus activity by extract s of Mimosa pudica, a unique Indian medicinal plant
  260. Anti-respiratory passage virus of Chinese herbal medicine
  261. Anti-respiratory syncytial virus compounds from two endophytic fungi isolated from nigerian medicinal plant s
  262. Anti-tumor Activity Of Virulent Newcastle virus With Urtica pilulifera On Mammary Adenocarcinoma In mice
  263. Anti-tumor-promoting effects of isoFLAVONOIDS on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
  264. Anti-viral Activities of Ficus Benjamina and Lilium Candidum
  265. Anti-viral Activities of Oroxylum indicum extract s on Chikungunya virus Infection
  266. Anti-viral activities of selected Kenyan medicinal plant s against the hepatitis-B virus
  267. Anti-viral Activity Evaluation of Selected Medicinal plant s of Nigeria against Measles virus
  268. Anti-viral Activity of Indian plant s
  269. Anti-viral effects of medicinal plant s in the management of dengue: a systematic review
  270. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine 

  271. Anti-virus activities of the extract and effective components isolated from Senecio cannabifolius less
  272. Anti-virus function of 5 kinds of total flavone ingredients in vitro
  273. Anti‐Hepatitis B virus Active Lactones from the Traditional Chinese Herb: Swertia mileensis
  274. Anti‑hepatitis B virus activity of Boehmeria nivea leaf extract s in human HepG2. 2.15 cells
  275. Anti‐hepatitis C virus activity of 3‐hydroxy caruilignan C from Swietenia macrophylla stems
  276. Anti‐hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species
  277. Anti‐influenza virus activity of crude extract of Ribes nigrum L.
  278. Anti‐influenza virus agents: Synthesis and mode of action
  279. Anti‐influenza virus effects of cocoa
  280. Anti–Herpes Simplex virus Type-1 Activity and Phenolic Content of Crude Ethanol extract and Four Corresponding Fractions of Quercus brantii L Acorn
  281. Antibacterial and antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review
  282. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin
  283. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species
  284. Antibacterial, antifungal, and antiviral activities of African medicinal plant s
  285. Antibacterial, antifungal, and antiviral activities of some flavonoids
  286. Anti-influenza virus effects of the aqueous extract from Mosla scabra
  287. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
  288. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics
  289. Anti-Mayaro virus activity of Cassia australis extract s (Fabaceae, Leguminosae)
  290. Anti-mumps virus activity by extract s of Mimosa pudica, a unique Indian medicinal plant
  291. Anti-respiratory passage virus of Chinese herbal medicine
  292. Anti-respiratory syncytial virus compounds from two endophytic fungi isolated from nigerian medicinal plant s
  293. Anti-tumor Activity Of Virulent Newcastle virus With Urtica pilulifera On Mammary Adenocarcinoma In mice
  294. Anti-tumor-promoting effects of isoFLAVONOIDS on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
  295. Anti-viral Activities of Ficus Benjamina and Lilium Candidum
  296. Anti-viral Activities of Oroxylum indicum extract s on Chikungunya virus Infection
  297. Anti-viral activities of selected Kenyan medicinal plant s against the hepatitis-B virus
  298. Anti-viral Activity Evaluation of Selected Medicinal plant s of Nigeria against Measles virus
  299. Anti-viral Activity of Indian plant s
  300. Anti-viral effects of medicinal plant s in the management of dengue: a systematic review
  301. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine 

  302. Anti-virus activities of the extract and effective components isolated from Senecio cannabifolius less
  303. Anti-virus function of 5 kinds of total flavone ingredients in vitro
  304. Anti‐Hepatitis B virus Active Lactones from the Traditional Chinese Herb: Swertia mileensis
  305. Anti‑hepatitis B virus activity of Boehmeria nivea leaf extract s in human HepG2. 2.15 cells
  306. Anti‐hepatitis C virus activity of 3‐hydroxy caruilignan C from Swietenia macrophylla stems
  307. Anti‐hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species
  308. Anti‐influenza virus activity of crude extract of Ribes nigrum L.
  309. Anti‐influenza virus agents: Synthesis and mode of action
  310. Anti‐influenza virus effects of cocoa
  311. Anti–Herpes Simplex virus Type-1 Activity and Phenolic Content of Crude Ethanol extract and Four Corresponding Fractions of Quercus brantii L Acorn
  312. Antibacterial and antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review
  313. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin
  314. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species
  315. Antibacterial, antifungal, and antiviral activities of African medicinal plant s
  316. Antibacterial, antifungal, and antiviral activities of some flavonoids
  317. Antibacterial, Antifungal, and antiviral Properties of Medical plant s
  318. Antibacterial, antiviral and antifungal activity of essential oils: Mechanisms and applications
  319. Antibacterial, antiviral and antioxidant activities of aerial part extract s of Peganum harmala L. grown in Tunisia
  320. Antibacterial, antiviral , and antifungal properties of wines and winery byproducts in relation to their flavonoid content
  321. Antibacterial, antiviral , antiproliferative and apoptosis‐inducing properties of Brackenridgea zanguebarica (Ochnaceae)
  322. Antibacterial, cytotoxicity and antiviral activities of Asplenium nidus
  323. Antibiofilm and antiviral Potential of Leaf extract s from Moringa oleifera and Rosemary (Rosmarinus officinalis Lam.)
  324. Antibiotic prescribing to the inpatients diagnosed with Malaria and viral fever in two tertiary care hospitals in Madhya Pradesh India
  325. Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae)
  326. Anticancer and antiviral activity of marine algae.
  327. Anticancer and antiviral Effects and Inactivation of S-Adenosyl-l-homocysteine Hydrolase with 5′-Carboxaldehydes and Oximes Synthesized from Adenosine and Sugar 

  328. Anticancer and antiviral estimation of three Ulmus pravifolia extract s and their chemical constituents
  329. Anticancer, antiviral , antibacterial, and antifungal properties in microalgae
  330. Antidengue potential of leaf extract s of Pavetta tomentosa and Tarenna asiatica (Rubiaceae) against dengue virus and its vector Aedes aegypti (Diptera 

  331. ANTIHEPATITIS C virus ACTIVITY OF INDONESIAN MAHOGANY (TOONA SURENI)
  332. Antiherpes virus activity of extract s from the medicinal plant Geranium sanguineum L.
  333. Antiherpetic activities of FLAVONOIDS against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)in vitro
  334. Antimicrobial and antiviral activities of grape seed extract s
  335. Antimicrobial and antiviral Activities of Two Seed Oil Samples of Cucurbita pepo L. and Their Fatty Acid Analysis
  336. Antimicrobial and antiviral activity-guided fractionation from Scutia buxifolia Reissek extract s
  337. Antimicrobial and antiviral effects of essential oils from selected Umbelliferae and Labiatae plant s and individual essential oil components
  338. Antimicrobial and antiviral properties of different types of propolis
  339. Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives
  340. Antimicrobial studies of Ficus benghalensis and Ficus racemosa on pathogenic viral diseases
  341. Antimicrobial, anthelmintic, and antiviral activity of plant s traditionally used for treating infectious disease in the similipal biosphere reserve, Odisha, India
  342. Antimicrobial, antioxidant, and antiviral activities of Retama raetam (Forssk.) Webb flowers growing in Tunisia
  343. Antimicrobial, antiviral activity and GC-MS analysis of essential oil extract ed from Achillea fragrantissima plant growing in Sinai Peninsula
  344. Antimicrobial, antiviral and antioxidant activities of “água-mel” from Portugal
  345. Antimicrobial, antiviral and immunomodulatory activity studies of Pelargonium sidoides (EPsÂź 7630) in the context of health promotion
  346. Antioxidant activities of extract s from five anti-viral medicinal plant s
  347. Antioxidant Activity of antiviral Proteins from Celosia cristata
  348. Antioxidant and anti-hepatitis c viral activities of commercial milk thistle food supplements
  349. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
  350. Antioxidant and antiviral activities of the aqueous alcoholic leaf extract of Boscia angustifolia A. Rich.(Capparaceae) and its major component’ombuin’
  351. Antioxidant and antiviral properties of Pseudopiptadenia contorta (Leguminosae) and of quebracho (Schinopsis sp.) extract s
  352. Antioxidant Status in Human immunodeficiency virus Infection in Different Clinical Conditions
  353. Antioxidant treatment regulates the humoral immune response during acute viral infection
  354. Antioxidant, antibacterial and antiviral properties of Goniothalamus umbrosus leaves methanolic extract
  355. Antioxidant, antibacterial, and antiviral effects of Lactuca sativa extract s
  356. Antioxidative and antiviral Properties of Flowering Cherry Fruits (Prunus serrulata L. var. spontanea)
  357. Antiplasmodial, anti-chikungunya virus and antioxidant activities of 64 endemic plant s from the Mascarene Islands
  358. Antiprotozoal, antiviral and cytotoxic properties of the Nigerian Mushroom, Hypoxylon fuscum Pers. Fr.(Xylariaceae)
  359. Antiretroviral agents against human immunodeficiency virus : an overview of current drugs and new perspectives
  360. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and 

  361. Antitumor Activities of Secondary Metabolites from Marine Microbe Stress Responses to virus Infection
  362. antiviral abilities of Curcuma kwangsiensis ingredients against grouper iridoviral infection in vitro and in vivo
  363. antiviral ability of Kalanchoe gracilis leaf extract against enterovirus 71 and coxsackievirus A16
  364. antiviral action of hydromethanolic extract of geopropolis from Scaptotrigona postica against antiherpes simplex virus (HSV-1)
  365. antiviral actions of flavanoid-derived compounds on dengue virus type-2
  366. antiviral activities of aerial subsets of Artemisia species against Herpes Simplex virus type 1 (HSV1) in vitro
  367. antiviral activities of atractylon from Atractylodis Rhizoma
  368. antiviral activities of biflavonoids
  369. antiviral activities of compounds from aerial parts of Salvia plebeia R. Br
  370. antiviral activities of Cucumis metuliferus fruits alkaloids on Infectious Bursal Disease virus (IBDV)
  371. antiviral Activities of Curcuma Genus against Hepatitis C virus
  372. antiviral activities of extract s and phenolic components of two Spondias species against dengue virus
  373. antiviral activities of extract s and selected pure constituents of Ocimum basilicum
  374. antiviral activities of extract s of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251
  375. antiviral activities of extremophilic actinomycetes extract s from Kazakhstan’s unique ecosystems against influenza virus es and paramyxovirus es
  376. antiviral activities of FLAVONOIDS and organic acid from Trollius chinensis Bunge
  377. antiviral activities of FLAVONOIDS isolated from the bark of Rhus verniciflua stokes against fish pathogenic virus es In Vitro
  378. antiviral activities of hedera helix containing hederasaponin B and phyllanthus urinaria containing corilagin against enterovirus infections
  379. antiviral Activities of Hibiscus sabdariffa L. Tea extract Against Human Influenza A virus Rely Largely on Acidic pH but Partially on a Low-pH-Independent 

  380. antiviral activities of hydroxylated flavone s on feline foamy viral proliferation
  381. antiviral activities of hypericin
  382. antiviral activities of Indonesian medicinal plant s in the East Java region against hepatitis C virus
  383. antiviral Activities of L-FMAUS, a new L-FMAU derivative, Against Hepatitis B virus
  384. antiviral activities of Lonicera japonica Thunb. Components against grouper iridovirus in vitro and in vivo
  385. antiviral activities of medicinal herbs traditionally used in southern mainland China
  386. antiviral activities of medicinal plant s of southern Nepal
  387. antiviral activities of mulberry (Morus alba) juice and seed against influenza virus es
  388. antiviral activities of natural compounds derived from traditional chinese medicines against porcine circovirus type 2 (PCV2)
  389. antiviral activities of plant s occurring in the state of Minas Gerais, Brazil: Part 2. Screening Bignoniaceae species
  390. antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae)
  391. antiviral activities of selected Chinese medicinal plant s
  392. antiviral activities of several oral traditional Chinese medicines against influenza virus es
  393. antiviral Activities of Silymarin and Derivatives
  394. antiviral activities of some Ethiopian medicinal plant s used for the treatment of dermatological disorders
  395. antiviral Activities of the Aqueous, Ethanolic and Methanolic extract s of Diospyros Mespiliformis leaf on some pathogenic Avian virus es.
  396. antiviral activity against herpes simplex virus of lipoic acid
  397. antiviral Activity Against Infectious Bronchitis virus and Bioactive Components of Hypericum perforatum L.
  398. antiviral activity and Antioxidant role Bedd in NDV induced ox
  399. antiviral activity and chemical composition of European and Egyptian propolis
  400. antiviral activity and chemical compositions of extract s from Myrica rubra
  401. antiviral Activity and Constituents of the Nepalese Medicinal plant Astilbe rivularis.
  402. antiviral activity and cytotoxicity of the lipophilic extract s of various edible plant s and their fatty acids
  403. antiviral activity and mode of action of a peptide isolated from Sorghum bicolor
  404. antiviral activity and mode of action of propolis extract s and selected compounds
  405. antiviral Activity and Molecular Targets of plant natural Products Against Avian Influenza virus
  406. antiviral Activity and Phytochemical Analysis of Ailanthus Excelsa Roxb Bark
  407. antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinovirus es
  408. antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinovirus es
  409. antiviral activity in vitro and in vivo of natural FLAVONOIDS isolated from Heliotropium sinuatum against infectious salmon anemia virus (ISAV)
  410. antiviral activity of [1, 2, 3] triazolo [4, 5-d] pyrimidin-7 (6H)-ones against chikungunya virus targeting the viral capping nsP1
  411. antiviral activity of 3 (2H)-and 6-chloro-3 (2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates
  412. antiviral activity of 3, 4′-dihydroxyflavone on influenza a virus
  413. antiviral activity of 5, 6, 7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir.
  414. antiviral Activity of a Arisaema Tortuosum Leaf extract and Some of its Constituents against Herpes Simplex virus Type 2
  415. antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza A H3N2 and hepatitis B virus in vitro
  416. antiviral activity of a synthesized shikonin ester against influenza a (H1N1) virus and insights into its mechanism
  417. antiviral activity of a zymolytic grain based extract on human immunodeficiency virus type 1 In Vitro
  418. antiviral activity of Acacia nilotica against Hepatitis C virus in liver infected cells
  419. antiviral activity of African medicinal plant s
  420. antiviral activity of Ageratina havanensis and major chemical compounds from the most active fraction
  421. antiviral Activity of Alhagi maurorum Medik’s Methanolic extract on Foot and Mouth Disease virus (FMDV) in Cell Cultures
  422. antiviral activity of Aloe hijazensis against some haemagglutinating virus es infection and its phytoconstituents
  423. antiviral Activity of Aloe hijazensis against Some Haemagglutinating virus es Infection and its Phytoconstituents
  424. antiviral activity of Alpinia katsumadai extract s against rotavirus es
  425. antiviral activity of Alternanthera Philoxeroides effective fractions extract s against virus A H3N2
  426. antiviral activity of antofine from Cynanchum komarovii
  427. antiviral activity of Arctigenin against Newcastle Disease virus in vitro
  428. antiviral Activity of Aspalathus linearis against Human Influenza virus
  429. antiviral activity of baicalein and quercetin against the Japanese encephalitis virus
  430. antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase
  431. antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses
  432. antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A virus and Its Neuraminidase Inhibition
  433. antiviral activity of betacyanins from red pitahaya (Hylocereus polyrhizus) and red spinach (Amaranthus dubius) against dengue virus type 2 (GenBank accession no 

  434. antiviral activity of Bifidobacterium adolescentis SPM 0214 against herpes simplex virus type 1
  435. antiviral activity of Bignoniaceae species occurring in the State of Minas Gerais (Brazil): part 1
  436. antiviral Activity of Bioflavonoid against Dengue virus Type-2
  437. antiviral activity of Bolivian plant extract s
  438. antiviral Activity of Cananga odorata Against Hepatitis B virus
  439. antiviral Activity of Cardiospermum Halicacabum L. extract against Coinfecting Agents HIV and HBV
  440. antiviral Activity of Cassia Alata and Cosmos Caudatus Leaf extract to Dengue virus Serotype-2 New Guinea C Strain in Huh7-it1 Cell
  441. antiviral activity of Ceiba pentandra and Eugenia uniflora leaf extract s to dengue virus serotype-2 in Huh 7it-1 cell line
  442. antiviral activity of characterized extract s from Echinacea spp.(Heliantheae: Asteraceae) against herpes simplex virus (HSV-I)
  443. antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase
  444. antiviral activity of Chongkukjang extract s against influenza A virus in vitro and in vivo
  445. antiviral activity of chrysin derivatives against coxsackievirus B3 in vitro and in vivo
  446. antiviral activity of Cleome rosea extract s from field-grown plant s and tissue culture-derived materials against acyclovir-resistant Herpes simplex virus es type 1 (ACVr 

  447. antiviral activity of compounds isolated from plant s
  448. antiviral Activity of Constituents Identified in Propolis against Human Rhinovirus and their Possible Mode of Action
  449. antiviral activity of Conyza canadensis (L.) Cronquist extract s grown in Tunisia
  450. antiviral activity of Corylus heterophylla fisch against porcine epidemic diarrhea virus infection
  451. antiviral activity of crude extract s from Commiphora swynnertonii against Newcastle disease virus in ovo
  452. antiviral activity of crude extract s of Eugenia jambolana Lam. against highly pathogenic avian influenza (H5N1) virus
  453. antiviral activity of crude hydroethanolic extract from Schinus terebinthifolia against Herpes simplex virus Type 1
  454. antiviral Activity of Cynometra ramiflora Linn Leaves extract Against Replication of Dengue virus Serotype 2 on Huh 7.5 Cell In Vitro
  455. antiviral activity of Dianthus superbusn L. against hepatitis B virus in vitro and in vivo
  456. antiviral Activity of Dicrocephala Integrifolia (Kuntze) Against Herpes Simplex Type-1 virus : An in vitro Study
  457. antiviral activity of Distictella elongata (Vahl) Urb. (Bignoniaceae), a potentially useful source of anti‐dengue drugs from the state of Minas Gerais, Brazil
  458. antiviral ACTIVITY OF ECHINACEA (ECHINACEA PURPUREA) REZA MOHAMMADHASSAN, SAEEDEH AKHAVAN 2, 3, AIDA MAHMOUDI, ATIEH 

  459. antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection
  460. antiviral activity of ethanol extract s of Ficus benjamina and its fractions in vitro
  461. antiviral activity of ethanol extract s of Ficus binjamina and Lilium candidum in vitro
  462. antiviral activity of Eucalyptus camaldulensis leaves ethanolic extract on herpes virus es infection
  463. antiviral activity of Euphorbia helioscopia extract
  464. antiviral Activity of Euphorbia Lectin Against Herpes Simplex virus 1 and its Antiproliferative Activity Against Human Cancer Cell-Line. J Antivir Antiretrovir 8 

  465. antiviral Activity of Extracellular Polysaccharide from Porphyridium sp. against Respiratory Syncytial virus (RSV).
  466. antiviral activity of extract s from Brazilian seaweeds against herpes simplex virus
  467. antiviral Activity of extract s from Wild Grasses against Epstein-Barr virus and Induction of Apoptosis in EBV-positive Lymphoblastoid Cells
  468. antiviral activity of Faramea bahiensis leaves on dengue virus type-2 and characterization of a new antiviral flavanone glycoside
  469. antiviral Activity of Faramea hyacinthina and Faramea truncata Leaves on Dengue virus Type‐2 and Their Major Compounds
  470. antiviral activity of few selected indigenous plant s against Bovine Herpes virus -1
  471. antiviral activity of five Asian medicinal pant crude extract s against highly pathogenic H5N1 avian influenza virus
  472. antiviral activity of five filamentous cyanobacteria against coxsackievirus B3 and rotavirus
  473. antiviral activity of flavone s and potentiation by ascorbate
  474. antiviral activity of FLAVONOIDS present in aerial parts of Marcetia taxifolia against Hepatitis B virus , Poliovirus , and Herpes Simplex virus in vitro
  475. antiviral activity of Flos verbasci infusion against influenza and Herpes simplex virus es.
  476. antiviral activity of four types of bioflavonoid against dengue virus type-2
  477. antiviral activity of Fridericia formosa (Bureau) LG Lohmann (Bignoniaceae) extract s and constituents
  478. antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens
  479. antiviral activity of geopropolis extract from Scaptotrigona aff. postica against Rubella virus .
  480. antiviral activity of herbal extract s against the hepatitis A virus
  481. antiviral activity of hop constituents against a series of DNA and RNA virus es
  482. antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus
  483. antiviral activity of Illicium verum Hook. f. extract s against grouper iridovirus infection
  484. antiviral activity of Isatidis Radix derived glucosinolate isomers and their breakdown products against influenza A in vitro/ovo and mechanism of action
  485. antiviral Activity of Isoorientin against Respiratory Syncytial virus in Vitro and in Vivo
  486. antiviral activity of Jinchai capsule against influenza virus
  487. antiviral activity of Justicia gendarussa Burm. f. leaves against HIV-infected MT-4 cells
  488. antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo
  489. antiviral Activity of Lady’s Mantle (Alchemilla vulgaris L.) extract s against Orthopoxvirus es
  490. antiviral Activity of latex from Ficus nitida against plant virus es
  491. antiviral ACTIVITY OF LATHAKARANJA (CAESALPINIA CRISTA L.) CRUDE extract S ON SELECTED ANIMAL virus ES
  492. antiviral activity of leaf-bud gum-resin of Tarenna asiatica
  493. antiviral activity of leaves extract s of Marrubium alysson L
  494. antiviral activity of luteolin against Japanese encephalitis virus
  495. antiviral activity of maca (Lepidium meyenii) against human influenza virus
  496. antiviral activity of medicinal plant extract s
  497. antiviral activity of medicinal plant s of Nilgiris
  498. antiviral activity of Mentha spicata Linn. extract s against porcine parvovirus in vitro
  499. antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia virus es
  500. antiviral activity of Momordica charantia: a preliminary study on in vitro anti herpes simplex virus
  501. antiviral activity of Myracrodruon urundeuva against rotavirus
  502. antiviral activity of myticin C peptide from mussel: an ancient defense against herpesvirus es
  503. antiviral activity of natural and semi-synthetic chromone alkaloids
  504. antiviral activity of natural occurring FLAVONOIDS in vitro
  505. antiviral activity of natural phloroglucinols and their analogues
  506. antiviral activity of nobiletin against chikungunya virus in vitro
  507. antiviral activity of obtained extract s from different parts of cupressus sempervirens against Herpes Simplex virus Type 1
  508. antiviral activity of oroxylin A against coxsackievirus B3 alleviates virus -induced acute pancreatic damage in mice
  509. antiviral activity of Panamanian plant extract s
  510. antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease
  511. antiviral activity of Petiveria alliacea against the bovine viral diarrhea virus
  512. antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virus
  513. antiviral activity of phytochemicals: a comprehensive review
  514. antiviral activity of phytochemicals: a current perspective
  515. antiviral activity of pinocembrin against Zika virus replication
  516. antiviral activity of plant components. 1st communication: FLAVONOIDS (author’s transl)
  517. antiviral activity of plant flavonoid, 5, 7, 4′-trihydroxy-8-methoxyflavone , from the roots of Scutellaria baicalensis against influenza A (H3N2) and B virus es
  518. antiviral activity of plant POLYPHENOLS
  519. antiviral activity of plant ago major extract s and related compounds in vitro
  520. antiviral activity of plant s and their isolated bioactive compounds: An update
  521. antiviral Activity of Polymethoxylated flavone s from “Guangchenpi”, the Edible and Medicinal Pericarps of Citrus reticulata ‘Chachi’
  522. antiviral activity of POLYPHENOLS extract s from Daucus carota against Herpes simplex virus type 1
  523. antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus
  524. antiviral activity of propolis special extract GH 2002 against Varicella zoster virus in vitro
  525. antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus
  526. antiviral activity of quercetin-3-ÎČ-OD-glucoside against Zika virus infection
  527. antiviral activity of Quercus persica L.: high efficacy and low toxicity
  528. antiviral activity of resveratrol against human and animal virus es
  529. antiviral activity of ribavirin and favipiravir against human astrovirus es
  530. antiviral activity of root extract s from Tagetes minuta against Herpes simplex virus (HSV-1)
  531. antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63
  532. antiviral activity of selected FLAVONOIDS against Chikungunya virus
  533. antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extract ed from Bupleurum rigidum and Scrophularia scorodonia
  534. antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro
  535. antiviral activity of silymarin against chikungunya virus
  536. antiviral activity of silymarin against Mayaro virus and protective effect in virus -induced oxidative stress
  537. antiviral Activity of SIO2–Polyphenol Composites Prepared Mechanochemically from plant Raw Materials
  538. antiviral activity of Solanum paniculatum extract and constituents
  539. antiviral activity of some plant oils against herpes simplex virus type 1 in Vero cell culture
  540. antiviral activity of some plant s used in Nepalese traditional medicine
  541. antiviral activity of some South American medicinal plant s
  542. antiviral activity of some Tunisian medicinal plant s against Herpes simplex virus type 1
  543. antiviral activity of ST081006 against the dengue virus
  544. antiviral activity of subcritical water extract of Brassica juncea against influenza virus A/H1N1 in nonfat milk
  545. antiviral activity of substituted homoisoFLAVONOIDS on enterovirus es
  546. antiviral activity of sulfated polysaccharide of Adenanthera pavonina against poliovirus in HEp-2 cells
  547. antiviral activity of sulfated polysaccharides carrageenan from some marine seaweeds
  548. antiviral activity of Terminalia
  549. antiviral activity of ternatin and meliternatin, 3-methoxyflavone s from species of Rutaceae
  550. antiviral activity of the crude n-hexane extract from leaves of Piper lepturum var. angustifolium (C. DC.) Yunck.(Piperaceae)
  551. antiviral activity of the dichloromethane extract s from Artocarpus heterophyllus leaves against hepatitis C virus
  552. antiviral Activity of the Essential Oil of Melaleuca alternifolia (Maiden amp; Betche) Cheel (Tea Tree) Against Tobacco Mosaic virus
  553. antiviral Activity of the Four Monomers of Isatis Tinctoria L Against Coxsackievirus B_3 in vitro
  554. antiviral activity of the fruit extract of Cucumis metuliferus E. Meye (Curcubitaceae) in chicks
  555. antiviral activity of the infusion (SHS‐174) from flowers of Sambucus nigra L., aerial parts of Hypericum perforatum L., and roots of Saponaria officinalis L. against 

  556. antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2)
  557. antiviral activity of the sea cucumber tegument extract (Pattalus mollis) on human rotavirus A (RVA)
  558. antiviral Activity of the Sesquiterpene Lactones from Centipeda minima against Influenza a virus in vitro
  559. antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2
  560. antiviral activity of theaflavin digallate against herpes simplex virus type 1
  561. antiviral activity of total flavonoid extract s from Selaginella moellendorffii Hieron against coxsackie virus B3 in vitro and in vivo
  562. antiviral activity of traditional Chinese medicinal plant s Dryopteris crassirhizoma and Morus alba against dengue virus
  563. antiviral Activity of Traditional Medicinal plant s against Human Influenza virus es: Potent Anti-Influenza Activity of Aspalathus linearis
  564. antiviral activity of Trichilia catigua bark extract s for herpesvirus and poliovirus
  565. antiviral activity of uridine derivatives of 2-deoxy sugars against tick-borne encephalitis virus
  566. antiviral activity of Veronica persica Poir. on herpes virus infection
  567. antiviral Activity of Vicoa indica Against Herpes Simplex virus
  568. antiviral activity of Zanthoxylum species against influenza virus
  569. antiviral activity on hantavirus and apoptosis of VERO cells of natural and semi-synthetic compounds from Heliotropium filifolium Resin
  570. antiviral activity-guided fractionation from Araucaria angustifolia leaves extract
  571. antiviral agents against African swine fever virus
  572. antiviral agents against Ebola virus infection: repositioning old drugs and finding novel small molecules
  573. antiviral agents from natural sources
  574. antiviral agents from selected Chinese herbal medicines
  575. antiviral agents in development for Zika virus infections
  576. antiviral agents of plant origin. Antiherpetic activity of acacetin
  577. antiviral Agents, RNA virus es (Other than HIV), and Orthopoxvirus es
  578. antiviral amentoflavone from Selaginella sinensis
  579. antiviral and Antibacterial Screening of Some Nigerian Medicinal plant extract s
  580. antiviral and antimicrobial activities of Paeonia lactiflora root constituents and structurally related compounds against human rhinovirus and gastrointestinal bacteria
  581. antiviral and antimicrobial assessment of some selected flavonoids
  582. antiviral and antimicrobial evaluation of some heterocyclic compounds from Turkish plant s
  583. antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species
  584. antiviral and antioxidant activities of FLAVONOIDS of Ficus virens: Experimental and theoretical investigations
  585. antiviral and antioxidant activities of sulfated galactomannans from plant s of Caatinga Biome
  586. antiviral and antioxidant activities of two medicinal plant s
  587. antiviral and Antioxidant Activity of a Hydroalcoholic extract from Humulus lupulus L.
  588. antiviral and antioxidant activity of FLAVONOIDS and proanthocyanidin s from Crataegus sinaica
  589. antiviral and antioxidant properties of echinochrome a
  590. antiviral and antiparasitic activities of clovamide: the major constituent of Dichrostachys cinerea (L.) wight et arn
  591. antiviral and antituberculous activity of Helichrysum melanacme constituents
  592. antiviral and antitumor activity of licorice root extract s
  593. antiviral and cytotoxic activities of anthraquinones isolated from Cassia roxburghii Linn. leaves
  594. antiviral and cytotoxic activities of some Indonesian plant s
  595. antiviral and cytotoxic evaluation of coumarins from Prangos ferulacea
  596. antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus
  597. antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds
  598. antiviral and immunomodulatory effects of Norantea brasiliensis choisy on dengue virus -2
  599. antiviral and immunomodulatory effects of POLYPHENOLS on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
  600. antiviral and immunomodulatory Properties of Meliaceae Family
  601. antiviral and immunostimulant activities of Andrographis paniculata
  602. antiviral and therapeutic uses of medicinal plant s and their derivatives against dengue virus es
  603. antiviral and virucidal activities of Duabanga grandiflora leaf extract against Pseudorabies virus in vitro
  604. antiviral and virucidal activities of natural products
  605. antiviral biFLAVONOIDS from Radix Wikstroemiae (Liaogewanggen)
  606. antiviral Chinese medicinal herbs against respiratory syncytial virus
  607. antiviral Chromones from the Stem of Cassia siamea
  608. antiviral clerodane diterpenoids from Dodonaea viscosa
  609. antiviral compounds in extract s of Korean seaweeds: Evidence for multiple activities
  610. antiviral dicaffeoyl derivatives from Elephantopus scaber
  611. antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance
  612. antiviral drug rodopes: evaluation of wound healing activity.
  613. antiviral drug therapy-exploiting medicinal plant s
  614. antiviral drugs
  615. antiviral drugs fit for a purpose
  616. antiviral drugs that target cellular proteins may play major roles in combating HIV resistance
  617. antiviral Effect and Mechanism of Scutellaria Baicalensis Georgi [J]
  618. antiviral effect assay of aqueous extract of EchiumAmoenum-Lagainst HSV-1
  619. antiviral effect of 7-(4-benzimidazole-butoxy)-coumarin on rhabdoviral clearance via Nrf2 activation regulated by PKCα/ÎČ phosphorylation
  620. antiviral effect of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus type 1 infection
  621. antiviral Effect of Alternanthera Philoxeroides Microemulsion on Coxsackie virus Group B_3 in Vitro
  622. antiviral effect of aqueous extract s from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro
  623. antiviral effect of Archidendron pauciflorum leaves extract to hepatitis C virus : An in vitro study in JFH-1 strain
  624. antiviral effect of baicalin phospholipid complex against duck hepatitis A virus type 1
  625. antiviral effect of catechins in green tea on influenza virus
  626. antiviral effect of Dureping Injection in mice infected by influenza virus FM1 strain [J]
  627. antiviral effect of epigallocatechin gallate on enterovirus 71
  628. antiviral effect of Epimedium koreanum extract
  629. antiviral effect of FLAVONOIDS on human virus es
  630. antiviral effect of FLAVONOIDS on the dengue virus
  631. antiviral effect of flavonol glycosides isolated from the leaf of Zanthoxylum piperitum on influenza virus
  632. antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus
  633. antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus
  634. antiviral effect of methylated flavonol isorhamnetin against influenza
  635. antiviral effect of octyl gallate against DNA and RNA virus es
  636. antiviral Effect of Phyllanthus amarus Leaf extract against Newcastle Disease virus in Broilers
  637. antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis
  638. antiviral effect of phytochemicals from medicinal plant s: Applications and drug delivery strategies
  639. antiviral effect of polyphenol rich plant extract s on herpes simplex virus type 1
  640. antiviral Effect of Pterocarpus indicus Willd Leaves extract Against Replication of Dengue virus (DENV) In Vitro
  641. antiviral effect of resveratrol in ducklings infected with virulent duck enteritis virus
  642. antiviral effect of resveratrol in piglets infected with virulent Pseudorabies virus
  643. antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus
  644. antiviral Effect of Sub Fraction Cassia alata Leaves extract to Dengue virus Serotype-2 strain New Guinea C in Human Cell Line Huh-7 it-1
  645. antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1
  646. antiviral effect of theaflavins against calicivirus es
  647. antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds
  648. antiviral effects of a Malaysia medicinal plant (Phyllanthus)
  649. antiviral effects of ABMA against herpes simplex virus type 2 in vitro and in vivo
  650. antiviral Effects of Baicalein on Human Cytomegalovirus in Vitro
  651. antiviral effects of baicalin combined with peramivir against pandemic 2009 H1N1 virus in vitro and in vivo
  652. antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection
  653. antiviral effects of blackberry extract against herpes simplex virus type 1
  654. antiviral effects of blueberry proanthocyanidin s against Aichi virus
  655. antiviral effects of Brazilian green and red propolis extract s on Enterovirus surrogates
  656. antiviral effects of grape seed extract against feline calicivirus , murine norovirus , and hepatitis A virus in model food systems and under gastric conditions
  657. antiviral effects of green tea (Camellia sinensis) against pathogenic virus es in human and animals (a mini-review)
  658. antiviral Effects of Houttuynia cordata Polysaccharide extract on Murine Norovirus -1 (MNV-1)—A Human Norovirus Surrogate
  659. antiviral Effects of Lactococcus lactis on Feline Calicivirus , A Human Norovirus Surrogate
  660. antiviral effects of Melia azedarach L. leaves extract s on Sindbis virus -infected cells
  661. antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model
  662. antiviral Effects of Mulberry (Morus alba) Juice and Its Fractions on Foodborne viral Surrogates
  663. antiviral effects of Nauclea latifolia on Newcastle disease virus (NDV)
  664. antiviral effects of novel herbal medicine KIOM-C, on diverse virus es
  665. antiviral effects of olea europaea leaves extract and interferon-beta on gene expression of newcastle disease virus
  666. antiviral effects of persimmon extract on human norovirus and its surrogate, bacteriophage MS2
  667. antiviral effects of plant -derived essential oils and pure oil components
  668. antiviral effects of POLYPHENOLS : Development of bio-based cleaning wipes and filters
  669. antiviral effects of saffron and its major ingredients
  670. antiviral effects of the constituents derived from Chinese herb medicines on infectious bursal disease virus
  671. antiviral effects on bacteriophages and rotavirus by cranberry juice
  672. antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum
  673. antiviral Efficacy of FLAVONOIDS against Enterovirus 71 Infection in Vitro and in Newborn Mice
  674. antiviral efficacy of Limonium densiflorum against HSV-1 and influenza virus es
  675. antiviral enantiomers of a bisindole alkaloid with a new carbon skeleton from the roots of Isatis indigotica
  676. antiviral evaluation of plant s from Brazilian atlantic tropical forest
  677. antiviral Flavans from the Leaves of Pithecellobium clypearia
  678. antiviral flavone s from the leaves of Nicotiana tabacum
  679. antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine
  680. antiviral Flavonoid‐Type C‐Glycosides from the Flowers of Trollius chinensis
  681. antiviral FLAVONOIDS from Alkanna orientalis
  682. antiviral FLAVONOIDS from Mosla scabra
  683. antiviral FLAVONOIDS from the root bark of Morus alba L.
  684. antiviral FLAVONOIDS from the Seeds of Aesculus chinensis
  685. antiviral glycosidic bisindole alkaloids from the roots of Isatis indigotica
  686. antiviral herbs-present and future
  687. antiviral In vitro activity of Hypericum perforatum l. extract on the human cytomegalovirus (HCMV)
  688. antiviral investigation on the FLAVONOIDS of Chamaesyce thymifolia
  689. antiviral isoflavonoid sulfate and steroidal glycosides
  690. antiviral Matrine-Type alkaloids from the Rhizomes of Sophora tonkinensis
  691. antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
  692. antiviral medication in sexually transmitted diseases. Part I: HSV, HPV
  693. antiviral medicinal plant s of Iran: A Review of Ethnobotanical evidence
  694. antiviral molecules of enterovirus es
  695. antiviral natural products against chronic hepatitis B: recent developments
  696. antiviral natural products and herbal medicines
  697. antiviral Oligo- and Polyribonucleotides Containing Selected Triazolo[2,3-a]purines
  698. antiviral Phenolic Compounds from Arundina gramnifolia
  699. antiviral phenolics from the leaves of Cleistocalyx operculatus
  700. antiviral phloroglucinols from New Zealand Kunzea species
  701. antiviral phytocompounds for drug development: a data mining studies
  702. antiviral phytocompounds target envelop protein to control Zika virus
  703. antiviral Potential and Molecular Insight into Neuraminidase Inhibiting Diarylheptanoids from Alpinia katsumadai
  704. antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease
  705. antiviral potential of aqueous extract s of some parts of Momordica balsamina plant against newcastle disease virus
  706. antiviral potential of Bulgarian medicinal plant s
  707. antiviral potential of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea
  708. antiviral potential of medicinal plant s against HIV, HSV, influenza, hepatitis, and coxsackievirus : A systematic review
  709. antiviral potential of natural compounds against influenza virus hemagglutinin
  710. antiviral potential of selected Indian medicinal (ayurvedic) plant s against herpes simplex virus 1 and 2
  711. antiviral potential of vegetables: can they be cost-effective agents for human disease?
  712. antiviral Potentials of Enantia chlorantha extract s on Yellow Fever virus Taiye R. Fasola1, Faderera A. Adeyemo1, Joseph A. Adeniji2 and Iheanyi O. Okonko3 

  713. antiviral potentials of medicinal plant s
  714. antiviral profile of brown and red seaweed polysaccharides against Hepatitis C virus
  715. antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety
  716. antiviral properties from plant s of the Mediterranean flora
  717. antiviral properties of essential oils of Foeniculum vulgare and Pimpinella anisum L
  718. antiviral properties of garlic cloves juice compared with onion bulbs juice against potato virus Y (PVY)
  719. antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1
  720. antiviral Properties of Orthosiphon stamineus Aqueous extract in Herpes Simplex virus Type 1 Infected Cells
  721. antiviral properties of phytochemicals
  722. antiviral Properties of Prodelphinidin B-2 3â€Č-O-Gallate from Green Tea Leaf
  723. antiviral Properties of Propolis
  724. antiviral properties of resveratrol against pseudorabies virus are associated with the inhibition of IÎșB kinase activation
  725. antiviral properties of the natural POLYPHENOLS delphinidin and epigallocatechin gallate against the flavivirus es West Nile virus , Zika virus , and dengue virus
  726. antiviral property and mechanisms of a sulphated polysaccharide from the brown alga Sargassum patens against Herpes simplex virus type 1
  727. antiviral prospective of Tinospora cordifolia on HSV-1
  728. antiviral screening of British Columbian medicinal plant s
  729. antiviral screening of forty-two Egyptian medicinal plant s
  730. antiviral sesquiterpenes from leaves of Nicotiana tabacum
  731. antiviral stereoisomers of 3, 5-bis (2-hydroxybut-3-en-1-yl)-1, 2, 4-thiadiazole from the roots of Isatis indigotica
  732. antiviral stilbene 1, 2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection
  733. antiviral strategies against human coronavirus es
  734. antiviral susceptibility of Herpes simplex virus es and its clinical correlates: a single center’s experience
  735. antiviral susceptibility of penciclovir resistant mutants derived from herpes simplex virus type 1 in various cell lines
  736. antiviral therapy for hepatitis C
  737. antiviral therapy for influenza
  738. antiviral Triterpenes from the Twigs and Leaves of Lyonia ovalifolia
  739. antiviral -guided fractionation and isolation of phenolic compounds from Limonium densiflorum hydroalcoholic extract
  740. antiviral , antibacterial and cytotoxic activities of South African plant s containing cardiac glycosides
  741. antiviral , antibacterial and vitamin C-synergized radical-scavenging activity of Sasa senanensis Rehder extract
  742. antiviral , antibacterial, anti-inflammatory and antipyretic effects of Chaiju oral liquid [J]
  743. antiviral , antimicrobial and anti-inflammatory activities of Urera baccifera (L.) Gaudich
  744. antiviral , antioxidant and toxicological evaluation of mangrove associate from South East coast of India
  745. antiviral , antioxidant and toxicological evaluation of mangrove plant from South East coast of India
  746. antiviral , Cytotoxicity, Antioxidant and Chemical Constituents of Adansonia digitata Grown in Egypt
  747. antiviral , embryo toxic and cytotoxic activities of Astragalus membranaceus root extract s.
  748. antiviral s against Chikungunya virus : Is the Solution in Nature?
  749. Apigenin inhibits African swine fever virus infection in vitro
  750. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway
  751. Apigenin inhibits enterovirus -71 infection by disrupting viral RNA association with trans-acting factors
  752. Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity
  753. Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
  754. Apoptosis of lymphocytes and monocytes infected with influenza virus might be the mechanism of combating virus and causing secondary infection by influenza
  755. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury
  756. Apple Pomace, a By-Product from the Asturian Cider Industry, Inhibits Herpes Simplex virus Types 1 and 2 In Vitro Replication: Study of Its Mechanisms of Action
  757. Application of high‐speed counter‐current chromatography for the isolation of antiviral eremophilenolides from Ligularia atroviolacea
  758. Application of radiobiological techniques in studying antioxidant mechanisms: evaluation of their radioprotective, antioxidative and antiviral activities
  759. Application of traditional Chinese medical herbs in prevention and treatment of respiratory syncytial virus
  760. Applications of Artificial Intelligence and Machine Learning in viral Biology
  761. Approaches and strategies for the treatment of influenza virus infections
  762. Arachidonic acid metabolism to eicosanoids in herpes virus -infected rabbit cornea.
  763. Argonaute 2 and antiviral Silencing in plant s
  764. Aronia melanocarpa and its components demonstrate antiviral activity against influenza virus es
  765. Asia is the mine of natural antiviral products for public health
  766. Assessment of a flavone -polysaccharide based prescription for treating duck virus hepatitis
  767. Assessment of antiviral activity for Lamiaceae family members against RNA and DNA virus models using cell-culture: in vitro study
  768. Assessment of antiviral and Photodynamic Inactivation Activity of Different Compounds Against Hepatitis A virus
  769. Assessment of Drug Binding Potential of Pockets in the NS2B/NS3 Dengue virus Protein
  770. Assessment of human-to-human transmissibility of avian influenza A (H7N9) virus across 5 waves by analyzing clusters of case patients in mainland China, 2013 

  771. Assessment of Multidrug-Resistant Organism and viral Pathogen Transmission From the Rooms of Hospitalized Patients to Healthcare Workers and the Hospital 

  772. Assessment of potency of PC-complexed Ocimum sanctum methanol extract in embryonated eggs against Influenza virus (H1N1)
  773. Assessment of the Effect of Baicalin on Duck virus Hepatitis
  774. Assessment of Traditional Chinese herbal Medicine plant extract s’ Potential to Inhibit Activity of Herpes Simplex virus Type 1
  775. Astragalus Membranaceus Treatment Protects Raw264. 7 Cells from Influenza virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
  776. Astragalus mongholicus (Fisch.) Bge improves peripheral Treg cell immunity imbalance in the children with viral myocarditis by reducing the levels of miR 

  777. Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis
  778. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR
  779. Attachment and Penetration of Acyclovir‐resistant Herpes Simplex virus are Inhibited by Melissa officinalis extract
  780. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-ÎșB signaling pathway in Influenza A virus 

  781. Authenticating apple cider vinegar’s home remedy claims: antibacterial, antifungal, antiviral properties and cytotoxicity aspect
  782. Avocado (Persea americana) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-ÎșB–dependent 

  783. Ayapana triplinervis Essential Oil and Its Main Component Thymohydroquinone Dimethyl Ether Inhibit Zika virus at Doses Devoid of Toxicity in Zebrafish
  784. Baicalein and baicalin as Zika virus inhibitors
  785. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice
  786. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
  787. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virus
  788. Baicalin is an inhibitor of subgroup J avian leukosis virus infection
  789. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
  790. Bay laurel (Laurus nobilis) as potential antiviral treatment in natural ly BQCV infected honeybees
  791. Bell palsy and herpes simplex virus
  792. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity
  793. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
  794. Betulinic acid exerts anti‐hepatitis C virus activity via the suppression of NF‐Îș B‐and MAPK‐ERK 1/2‐mediated COX‐2 expression
  795. Beyond the Biological Effect of a Chemically Characterized Poplar Propolis: Antibacterial and antiviral Activity and Comparison with Flurbiprofen in cytokine s Release 

  796. Bicyclic octahydrocyclohepta [b] pyrrol-4 (1H) one derivatives as novel selective anti-hepatitis C virus agents
  797. Biflavanone s, Flavonoids, and Coumarins from the Roots of Stellera chamaejasme and Their antiviral Effect on Hepatitis B virus
  798. Astragalus Membranaceus Treatment Protects Raw264. 7 Cells from Influenza virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
  799. Astragalus mongholicus (Fisch.) Bge improves peripheral Treg cell immunity imbalance in the children with viral myocarditis by reducing the levels of miR 

  800. Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis
  801. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR
  802. Attachment and Penetration of Acyclovir‐resistant Herpes Simplex virus are Inhibited by Melissa officinalis extract
  803. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-ÎșB signaling pathway in Influenza A virus 

  804. Authenticating apple cider vinegar’s home remedy claims: antibacterial, antifungal, antiviral properties and cytotoxicity aspect
  805. Avocado (Persea americana) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-ÎșB–dependent 

  806. Ayapana triplinervis Essential Oil and Its Main Component Thymohydroquinone Dimethyl Ether Inhibit Zika virus at Doses Devoid of Toxicity in Zebrafish
  807. Baicalein and baicalin as Zika virus inhibitors
  808. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice
  809. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
  810. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virus
  811. Baicalin is an inhibitor of subgroup J avian leukosis virus infection
  812. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
  813. Bay laurel (Laurus nobilis) as potential antiviral treatment in natural ly BQCV infected honeybees
  814. Bell palsy and herpes simplex virus
  815. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity
  816. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
  817. Bioactive compounds screening from Zingiberaceae family as influenza a/swine flu virus neuraminidase inhibitor through docking approach
  818. Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle
  819. Bioactive natural products with anti‐herpes simplex virus properties
  820. Bioactivity-guided fractionation and analysis of compounds with anti-influenza virus activity from Gardenia jasminoides ellis
  821. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of Cyperus rotundus
  822. Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves
  823. Biocomputational approaches towards deciphering anti-dengue viral properties of synthetic and natural moieties
  824. Bioguided isolation of an antiviral compound from Xylophragma myrianthum (Cham.) Sprague (Bignoniaceae Juss.)
  825. BioHealthBase: informatics support in the elucidation of influenza virus host–pathogen interactions and virulence
  826. Biological assessment (antiviral and antioxidant) and acute toxicity of essential oils from Drimys angustifolia and D. brasiliensis
  827. Biological characteristics of dengue virus and potential targets for drug design
  828. Biomarkers for virus -induced hepatocellular carcinoma (HCC)
  829. Biophysical and flavonoid-binding studies of the G protein ectodomain of group A human respiratory syncytial virus
  830. Bioprospecting of Red Sea Sponges for Novel antiviral Pharmacophores
  831. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3, 11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin
  832. Blocking HCV entry as potential antiviral therapy
  833. Boerhaavia diffusa-Derived antiviral Glycoprotein: A Novel, Eco-friendly Approach for the Management of viral Diseases
  834. Breaking Down the Barriers to a natural antiviral Agent: antiviral Activity and Molecular Docking of Erythrina speciosa extract , Fractions, and the Major Compound
  835. Brief Report: Disseminated Mycobacteriosis Caused by Drug-Resistant Mycobacterium triplex in a Human immunodeficiency virus -Infected Patient during Highly 

  836. Broad-spectrum antiviral properties of andrographolide
  837. Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza virus es
  838. Budget Impact Analysis of Oral antiviral Agents for the Treatment of Chronic Hepatitis B in South Korea
  839. Bystander effect mediated by herpes simplex virus -thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation
  840. C-Methylated Flavonoid Glycosides from Pentarhizidium orientale Rhizomes and Their Inhibitory Effects on the H1N1 Influenza virus
  841. c‐Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide–dependent impairment of oxidative 

  842. CAM/Drug-Induced Hepatotoxicity: Implications in viral Hepatitis
  843. Can ethnopharmacology contribute to the development of antiviral drugs?
  844. Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
  845. Cancer chemopreventive activity of flavanone s on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
  846. Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus 

  847. Carnosine markedly ameliorates H9N2 swine influenza virus -induced acute lung injury
  848. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus -positive gastric cancer.
  849. CD 38 modulates respiratory syncytial virus ‐driven proinflammatory processes in human monocyte‐derived dendritic cells
  850. CD46, a primate-specific receptor for measles virus
  851. Cellular models for the screening and development of anti-hepatitis C virus agents
  852. Changes in the Hemagglutinin and Neuraminidase Genes of Avian H9N2 Influenza virus Adapted in Embryonated Chicken Eggs
  853. Changes in viral load in different organs of Japanese Encephalitis virus ‑infected chick embryo under the influence of Belladonna 200C
  854. Changes of SOD activity and MDA level in young ducks infected with new type duck hepatitis virus [J]
  855. Changes of the Activities of SOD, CAT and GSH Px and the Level of MDA in Chicks Infected with Virulent Marek’s Disease virus [J]
  856. Characteristcs of Pathogen-specific Memory T cells in the Liver during acute viral infection
  857. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense
  858. Characterization of a novel human-specific STING agonist that elicits antiviral activity against emerging alphavirus es
  859. Characterization of alginic acid extract ed from sargassum wightii and determination of its antiviral activity on shrimp penaeus monodon postlarvae against white 

  860. Characterization of anti‐Coxsackie virus B3 constituents of Radix Astragali by high‐performance liquid chromatography coupled with electrospray ionization tandem 

  861. Characterization of Whey Protein Isolate Covalently Modified with Phenolic Compounds 1: Antioxidant and antiviral Activities
  862. Chemical components from the twigs of Caesalpinia latisiliqua and their antiviral activity
  863. Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extract s from Cornus canadensis
  864. Chemical Composition and antiviral Activity of Essential Oils from Citrus reshni hort. ex Tanaka (Cleopatra mandarin) Cultivated in Egypt
  865. Chemical Composition and antiviral Effect of extract s of Origanum vulgare
  866. Chemical composition of Propolis extract ACFÂź and activity against herpes simplex virus
  867. Chemical composition, antiviral against avian influenza (H5N1) virus and antimicrobial activities of the essential oils of the leaves and fruits of Fortunella 

  868. Chemical compositions, antiviral and antioxidant activities of seven essential oils
  869. Chemical Constituents and Anti-influenza viral Activity of the Leaves of Vietnamese plant Elaeocarpus tonkinensis.
  870. Chemical constituents and antiviral activity of Polygala fallax [J]
  871. Chemical constituents and antiviral study of Goniothalamus velutinus
  872. Chemical constituents from Chirita longgangensis var. hongyao with inhibitory activity against porcine respiratory and reproductive syndrome virus
  873. Chemical constituents from Lobelia chinensis and their anti-virus and anti-inflammatory bioactivities
  874. Chemical constituents from Melicope pteleifolia leaves and their anti-influenza virus activities
  875. Chemical constituents of Swertia yunnanensis and their anti-hepatitis B virus activity
  876. Chemical studies on constituents of some antiviral plant extract s
  877. Chemically-coupled-peptide-promoted virus nanoparticle templated mineralization
  878. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein–Barr virus early antigen activation assay and the mouse skin two-stage 

  879. Chemotherapy: antiviral agents come of age
  880. Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
  881. Chikungunya virus drug discovery: still a long way to go?
  882. Chinese herbal medicine for carriers of the hepatitis B virus : an updated systematic review and meta-analysis
  883. Chromatographic Methods for Metabolite Profiling of virus – and Phytoplasma-Infected plant s of Echinacea purpurea
  884. chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
  885. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-ÎșB signal transduction pathway
  886. Cissampelos sympodialis has anti-viral effect inhibiting dengue non-structural viral protein-1 and pro-inflammatory mediators
  887. Cladogynos orientalis Zipp. extract s inhibit cell culture-derived hepatitis C virus genotype 2a replication in Huh-7 cells through NS5B inhibition
  888. Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities
  889. Clinical efficacy of L-carnitine in treating acute virus myocarditis
  890. Clinical Efficacy of SNMC in the Treatment Hepatic Fibrosis with Hepatitis B virus
  891. Clinical Observation of Chronic viral Hepatitis B Treated by Baicalin Capsules Combined with Adefovir Dipivoxil Tablets
  892. Clinical Observation of Compound Artemisiae Rupestris Granules Plus Other Traditional Chinese and Western Medicines in Treatment of viral Myocarditis
  893. Clinical Observation on Compound Glycyrrhizin Injection Combined with Alprostadil Injection for Severe Cholestatic virus Hepatitis [J]
  894. Clinical Observation on Pudilan Anti-inflammatory Oral Liquid for Treating viral Keratitis
  895. Clinical Research of Treating viral Infection of Upper Respiratory Tract in Children with Interferon Alpha 1b Atomized Inspiring [J]
  896. Clinical research on Shennong Gankang mixture curing viral hepatitis hyperbilirubinemia
  897. Clinoco-epidemic features of patients with chronic hepatitis C considering virus genotype in the Samara region
  898. Cloning and prokaryotic expression of binding protein 4 spliced variant HBeBP4A of hepatitis B virus e antigen
  899. Cloning and Sequencing of HA Gene of Avian Influenza virus Strain A/Font Monmouth/47 (H1N1)
  900. Coinfection with Epstein–barr virus (EBV), Human Papilloma virus (HPV) and Polyoma BK virus (BKPyV) in laryngeal, oropharyngeal and oral cavity cancer
  901. Combined action of antiviral substances of natural and synthetic origin. I. The anti-influenza action of a combination of the polyphenol complex isolated from Geranium 

  902. Combined Anti-influenza virus Effect of Synthetic and natural viral Inhibitors
  903. Combined antiinfluenza virus activity of Flos verbasci infusion and amantadine derivatives
  904. Combined antiinfluenza virus effect of a plant preparation and a bacterial protease inhibitor
  905. Combined antiviral effects of FLAVONOIDS and 5-ethyl-2′-deoxyuridine on the multiplication of herpesvirus es.
  906. Combined effect of selected antiviral substances of natural and synthetic origin. II. Anti-influenza activity of a combination of a polyphenolic complex isolated from 

  907. Combined therapy and precaution for viral myocarditis
  908. Combining Protein Interactions and Functionality Classification in NS3 to Determine Specific antiviral Targets in Dengue
  909. Commentary: The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb
  910. Comparative analysis of cytokine s in children with chronic virus hepatitis В and C
  911. Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein
  912. Comparative Antioxidant Study of Stem and Stem Induced Callus of Phyllanthus fraternus Webster—An Important antiviral and Hepatoprotective plant
  913. Comparative antiviral Activities of Diospyros Mespiliformis and Quisqualis indica Leaf extract s on Newcastle Disease.
  914. Comparative characteristic of clinical features of replicative and integrative phases of chronic virus hepatites B in children and teenagers
  915. Comparative evaluation of in-vitro cytotoxicity, antiviral and antioxidant activities of different soyasapogenols from soybean saponin
  916. Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus 

  917. Comparative Study on In Vitro Activities of Citral, Limonene and Essential Oils from Lippia citriodora and L. alba on Yellow Fever virus
  918. Comparative Study on the Main Herbs of Lonicerae and Forsythiae Powder Inhibiting Influenza virus in Vitro [J]
  919. Comparison between in vitro antiviral effect of Mexican propolis and three commercial FLAVONOIDS against canine distemper virus
  920. Comparison between In Vitro antiviral Effect of Mexican Propolis and Three Commercial FLAVONOIDS against Canine Distemper virus
  921. Comparison of in vitro antiviral activity of tea POLYPHENOLS against influenza A and B virus es and structure–activity relationship analysis
  922. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate
  923. Comparison of the antiviral activity of FLAVONOIDS against murine norovirus and feline calicivirus
  924. Comparison of the effects of glycyrrhiza and glycyrrhiza acid on the anti-respiratory syncytial virus in vitro [J]
  925. Complex compounds of zinc and copper(ii) ions with dihydroquercetin and their antiviral activity
  926. Complex formation of quercetin with lanthanum enhances binding to plant viral satellite double stranded RNA
  927. Compounds from rose (Rosa rugosa) flowers with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity
  928. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture
  929. Comprehensive characterisation of POLYPHENOLS in leaves and stems of three anti‐dengue virus type‐2 active Brazilian Faramea species (Rubiaceae) by HPLC‐DAD 

  930. Computational breakthrough of natural lead hits from the genus of Arisaema against human respiratory syncytial virus
  931. Computational Drug Design against Ebola virus Targeting viral Matrix Protein VP30
  932. Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus
  933. Computational insight into flavonoid-based compound for inhibition activity on SAH-binding site of dengue virus NS5 methyltransferase: Molecular docking and in 

  934. Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific 

  935. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
  936. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus
  937. Computational Simulation of Studying Zika virus : from Macroscale to Nanoscale
  938. Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase
  939. Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies
  940. Computer-aided docking studies of phytochemicals from plant s Salix subserrata and Onion as inhibitors of glycoprotein G of rabies virus
  941. Computer-Aided Drug Design for NS5 Protein of Zika virus
  942. Computer-aided drug design of broad-spectrum antiviral compounds
  943. Concurrent juvenile cellulitis and metaphyseal osteopathy: an atypical canine distemper virus syndrome?
  944. Confirmation of the antiviral properties of medicinal plant s via chemical analysis, machine learning methods and antiviral tests: a methodological approach
  945. Conjugated bilirubin increases T regulatory cell suppressor function during hepatitis A virus infection through a T cell immunoglobulin and mucin domain 

  946. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
  947. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus
  948. Constructions of hepatitis C virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells
  949. Contribution of autophagy to antiviral immunity
  950. Conversion of quassinoids for enhancement of inhibitory effect against Epstein-Barr virus early antigen activation. Introduction of lipophilic side chain and esterification 

  951. Correlation between oxidation potentials and inhibitory effects on Epstein–Barr virus activation of flavonoids
  952. Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
  953. Cost-effectiveness analysis of zedoary turmeric oil and ribavirin in treatment of viral pneumonia of children
  954. Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1
  955. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with ‘nutraceuticals’?
  956. Curcumin shows antiviral properties against norovirus
  957. Current and future anti-influenza virus drugs
  958. Current and future targets of antiviral therapy in the hepatitis C virus life cycle
  959. Current breakthroughs in structure-based design of synthetic and natural sourced inhibitors against zika viral targets
  960. Current landscape and future prospects of antiviral drugs derived from microbial products
  961. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
  962. Current status of natural products from plant s as anti-herpes simplex virus 1 agents
  963. Cyclin-dependent kinases as cellular targets for antiviral drugs
  964. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A
  965. CYSTUS052, a polyphenol-rich plant extract , exerts anti-influenza virus activity in mice
  966. CYTOTOXIC AND ANTI-viral ACTIVITY OF Acacia catechu ON HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
  967. Cytotoxic and antiviral compounds from bryophytes and inedible fungi
  968. Cytotoxic and antiviral potentials of Euphorbia milii var. splendens leaf against Peste des petits ruminant virus
  969. Cytotoxic and antiviral triterpenoids from the mangrove plant Sonneratia paracaseolaris
  970. Cytotoxic effect (on tumor cells) and in vitro antiviral activity against herpes simplex virus of synthetic spongiane diterpenes
  971. Cytotoxic, antimicrobial and antiviral secondary metabolites produced by the plant pathogenic fungus Cytospora sp. CCTU A309
  972. Cytotoxicity and antiviral activities of Asplenium nidus, Phaleria macrocarpa and Eleusine indica
  973. Cytotoxicity and antiviral activity evaluation of Cymbopogon spp hydroethanolic extract s
  974. Cytotoxicity and antiviral activity of Annona muricata aqueous leaves extract against dengue virus type 2
  975. Cytotoxicity and antiviral activity of methanol extract from Polygonum minus
  976. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum
  977. Cytotoxicity, antiviral and antimicrobial activities of alkaloids , flavonoids, and phenolic acids
  978. Daphne Genkwa sieb. Et zucc. Water-soluble extract s act on enterovirus 71 by inhibiting viral entry
  979. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
  980. Decrease in Dengue virus -2 infection and reduction of cytokine /chemokine production by Uncaria guianensis in human hepatocyte cell line Huh-7
  981. Delivery of Vaccinia virus Complement Control Protein (VCP) and Curcumin to the rodents’ brain: implications in Alzheimer’s disease and HIV dementia
  982. Dengue antiviral activity of polar extract from Melochia umbellata (Houtt) Stapf var. Visenia
  983. Dengue virus Disease: Current Updates on the use of Carica Papaya Leaf extract as a Potential herbal Medicine
  984. Dengue virus immunopathogenesis: Lessons applicable to the emergence of Zika virus
  985. Dengue virus infections and anti-dengue virus activities of Andrographis paniculata
  986. Dengue virus Inhibition Targets: A Review and Docking Study
  987. Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B–NS3 proteases
  988. Design and Synthesis of Various 6′-Modified Novel Nucleoside Analogues as Potent antiviral Agents
  989. Design, synthesis, and anti-influenza viral activities of 1, 3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors
  990. Design, Synthesis, antiviral Activities of Novel Phosphonate Derivatives Containing Quinazoline Based on Chalone Motif
  991. Designer Polymers for Non-viral Gene Transfection
  992. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein
  993. Designing antiviral Substances Targeting the Ebola virus viral Protein 24
  994. Designing Ecofriendly Bionanocomposite Assembly with Improved Antimicrobial and Potent on-site Zika virus Vector Larvicidal Activities with its Mode of 

  995. Detection of a Vero Cell-adapted H3N2 Influenza virus Strain by ELISA Method
  996. Detection of amphipathic viral peptide on screen-printed electrodes by liposome rupture impact voltammetry
  997. Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and 

  998. DETERMINATION OF ANTI-RABIES virus ACTIVITIES OF CRUDE extract S FROM SOME TRADITIONALLY USED MEDICINAL plant S IN EAST WOLLEGA 

  999. Determination of antioxidant activity, phenolic contents and antiviral potential of methanol extract of Euphorbia spinidens Bornm (Euphorbiaceae)
  1000. Determination of antiviral Activities of Quisqualis indica leaf extract s on Three Selected Avian virus es
  1001. Determination of antiviral activity and cytotoxicity of selected sage (Salvia L.) species
  1002. Determination of the content of flavonoid in the active fraction against influenza virus of Yinqiao powder
  1003. Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A
  1004. Development of a Cell-Based Hepatitis C virus (HCV) Infection FRET Assay for High Throughput antiviral Compound Screening
  1005. Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening
  1006. Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles
  1007. Development of a virus -induced gene silencing (VIGS) system for Spinacia oleracea L.
  1008. Development of Anti-viral Agents from natural Sources
  1009. Development of anti-viral agents using molecular modeling and virtual screening techniques
  1010. Development of antiviral therapy for severe acute respiratory syndrome
  1011. Development of chemical inhibitors of the SARS coronavirus : viral helicase as a potential target
  1012. Development of neuraminidase inhibitors as anti‐influenza virus drugs
  1013. Development of Oligonucleotide Therapeutics as antiviral Agents
  1014. Development of Small-Molecule Inhibitors Against Zika virus Infection
  1015. Develpment of Novel Carbocyclic Nucleosides as Potent antiviral and Antitumor Agents
  1016. Dietary FLAVONOIDS and modulation of natural killer cells: implications in malignant and viral diseases
  1017. Different inhibitory potencies of oseltamivir carboxylate, zanamivir, and several tannins on bacterial and viral neuraminidases as assessed in a cell-free fluorescence 

  1018. Differential alterations of glutathione S-transferase enzyme activities in three sorghum varieties following viral infection
  1019. Differential antiviral and anti-inflammatory mechanisms of the FLAVONOIDS biochanin A and baicalein in H5N1 influenza A virus -infected cells
  1020. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and 

  1021. Digallate dimers of (−)-epigallocatechin gallate inactivate herpes simplex virus
  1022. Dimeric Matrine-Type alkaloids from the Roots of Sophora flavescens and Their Anti-Hepatitis B virus Activities
  1023. Dioscin’s antiviral effect in vitro
  1024. Dioxin-induced deregulation of neutrophil recruitment to the lungs of mice infected with influenza virus
  1025. Direct virucidal action against influenza virus of an extract of Punica granatum L (granada)
  1026. Discordant Activity of Kaempferol Towards Dengue virus and Japanese Encephalitis virus
  1027. Discovery and characterization of diazenylaryl sulfonic acids as inhibitors of viral and bacterial neuraminidases
  1028. Discovery of a new sesquiterpenoid from Phellinus ignarius with antiviral activity against influenza virus
  1029. Discovery of a series of novel compounds with moderate anti-avian H5N1 influenza virus activity in chick embryo
  1030. Discovery of antiviral molecules for dengue: In silico search and biological evaluation
  1031. Discovery of Dengue virus Inhibitors
  1032. Discovery of natural ly occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase
  1033. Discovery of novel natural FLAVONOIDS as potent antiviral candidates against hepatitis C virus NS5B polymerase
  1034. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping
  1035. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design
  1036. Discovery of prenylated FLAVONOIDS with dual activity against influenza virus and Streptococcus pneumoniae
  1037. Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approaches
  1038. Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science
  1039. Discussion about traditional Chinese medicine anti-hepatitis B virus and its research ideas
  1040. Discussion on pathogenesis of viral myocarditis based on theory of the spleen and stomach [J]
  1041. Disruption of virus -host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections
  1042. Distinct molecular signatures in dissolved organic matter produced by viral lysis of marine cyanobacteria
  1043. Divergent antiviral effects of bioFLAVONOIDS on the hepatitis C virus life cycle
  1044. Diversity of pharmacological properties in Chinese and European medicinal plant s: cytotoxicity, antiviral and antitrypanosomal screening of 82 herbal drugs
  1045. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
  1046. DNA related enzymes as molecular targets for antiviral and antitumoral chemotherapy. A natural overview of the current perspectives
  1047. DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
  1048. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites
  1049. Docking of Phytoconstituents of Cynodon dactylon on NS2B NS3 protease domain of Dengue virus
  1050. Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target
  1051. Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase
  1052. Does an apple a day keep the doctor away because a phytoestrogen a day keeps the virus at bay? A review of the anti-viral properties of phytoestrogens
  1053. Does hepatitis B virus infection cause breast cancer
  1054. Domain dissection of large polyproteins as a tool for structure-function studies: Examples from bacterial polyketide synthases and viral replicases
  1055. Doratoxylon apetalum, an indigenous medicinal plant from Mascarene Islands, is a potent inhibitor of Zika and dengue virus infection in human cells
  1056. Down-regulation of flavonoid 3â€Č-hydroxylase gene expression by virus -induced gene silencing in soybean reveals the presence of a threshold mRNA level 

  1057. Drosophila as a model for antiviral immunity
  1058. Drug resistance of human immunodeficiency virus and overcoming it by natural products
  1059. Drug targets for corona virus : A systematic review.
  1060. Drug–drug interactions during antiviral therapy for chronic hepatitis C
  1061. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease
  1062. Ebola viral protein 24 (VP24) inhibitor discovery by In silico fragment-based design
  1063. Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission
  1064. EBV-associated cancers: Strategies for targeting the virus
  1065. Ecological mechanisms that promote arbovirus survival: a mathematical model of Ross River virus transmission
  1066. Ectromelia virus upregulates the expression of heat shock protein 70 to promote viral replication
  1067. Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog virus 3 (author’s transl)
  1068. Effect of ampelopsis of ampelopsis grossedentata on duck hepatitis B virus
  1069. Effect of antiviral substances on hepatitis A virus replication in vitro
  1070. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza
  1071. Effect of Argemone mexicana active principles on inhibiting viral multiplication and stimulating immune system in Pacific white leg shrimp Litopenaeus vannamei 

  1072. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system
  1073. Effect of baicalin on in vivo anti-virus
  1074. Effect of cacao husk extract on human immunodeficiency virus infection
  1075. Effect of Dietary Soy Genistein on Pig Growth and immune Response during a viral Challenge
  1076. Effect of Egyptian propolis on the susceptibility of LDL to oxidative modification and its antiviral activity with special emphasis on chemical composition
  1077. Effect of freeze-dried Carica papaya leaf juice on inflammatory cytokine s production during dengue virus infection in AG129 mice
  1078. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors
  1079. Effect of Hippophae rhamnoides leaf extract against Dengue virus infection in human blood-derived macrophages
  1080. Effect of Honeysuckble Compound Preparation on Proliferation of Lymphocytes in immune Organs of Chickens Infected with Newcastle Disease virus
  1081. Effect of Huang Jin Fang in the prevention and treatment of influenza A H_1N_1 virus in mice [J]
  1082. Effect of Huang Jin Fang on influenza virus load and immunity in mice
  1083. Effect of Infectious Bursal Disease virus on Oxidation-antioxidution Ability of Chickens
  1084. Effect of interferon-α2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study
  1085. Effect of interleukin-18 combined with high-dose vitamin C on viral myocarditis [J]
  1086. Effect of Korean arbor vitae (Thuja koraiensis) extract on antimicrobial and antiviral activity
  1087. Effect of modified amantadine on immune function of mice infected with influenza A (H5N1) virus
  1088. Effect of Moringa oleifera feed supplementation on the serum biochemical profile of broilers challenged with very virulent infectious bursal disease virus
  1089. Effect of naringenin, hesperetin and their glycosides forms on the replication of the 17D strain of yellow fever virus
  1090. Effect of nuclear polyhedrosis virus infection on the activity of carboxylesterase and glutathione s-transferase in Helicoverpa armigera (Hbn)
  1091. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection1
  1092. Effect of p-fluorophenylalanine on the multiplication of foot-and-mouth disease virus
  1093. EFFECT OF PHYTONUTRIENT ‘VITASTIM’ON CHICKEN MUCOSAL IMMUNITY AGAINST LOW PATHOGENIC AVIAN INFLUENZA virus H4N6
  1094. Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus
  1095. Effect of propolis extract on malignant cell transformation by moloney murine sarcoma virus
  1096. Effect of quercetin on hepatitis C virus life cycle: from viral to host targets
  1097. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection
  1098. Effect of quercetin on the course of mengo virus infection in immunodeficient and normal mice. A histologic study.
  1099. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection
  1100. Effect of root extract from Boerhaavia diffusa L., containing an antiviral principle upon plaque formation of RNA bacteriophages
  1101. Effect of Sheng Mai San on the Symptoms and the Markers of Inflammatory Damage in Patients with Acute viral Myocarditis
  1102. Effect of Silybin on Coxsackie B_5 virus Infected New Born Rat Heart Cells in Culture [J]
  1103. Effect of Skullcap Bupleurum Chinense and Compatibility extract on Expression of CVB3m-RNA and IFN mRNA in the Myocardium in Mice with viral Myocarditis [J]
  1104. Effect of some neem products on transmission of cotton leaf curl virus through Bemisia tabaci.
  1105. Effect of tannic acid on the development and resistance of the gypsy moth Lymantria dispar L. to viral infection
  1106. Effect of the antiviral compound MDL 20,610 on some aspects of murine immune function
  1107. Effect of the Water extract from Helicteres angustifolia on Activity of SOD and Contents of NO, LPO in Duck Model for Chronic Hepatitis B virus Infection
  1108. Effect of total FLAVONOIDS of Scutellaria baicalensis Georgi on expression of influenza A virus nucleoprotein in HeLa cells
  1109. Effect of treatment with certain FLAVONOIDS on Mengo virus -induced encephalitis in mice
  1110. Effect of ultrasound technology combined with binary mixtures of ethanol and water on antibacterial and antiviral activities of Erodium glaucophyllum extract s
  1111. Effect of viola yedoensis makino on hepatitis B virus detected by laser confocal scanning microscopy
  1112. Effect of vitamin A on tumor development in burned, unburned, and glucocorticoid-treated mice inoculated with an oncogenic virus
  1113. Effect of Yin-Qiao-Jie-Du Pill on ÎČ-defensin1’s Expression in Lung Tissue of Mice Infected With Influenza A virus [J]
  1114. Effect of Yixinkang soup on cardiocytes of suckling rats infected by CVB_3 virus [J]
  1115. Effect on non-steroidal anti-inflammatory drugs on Moloney sarcoma virus inoculated mice
  1116. Effective antiviral medicinal plant s and biological compounds against central nervous system infections: A mechanistic review.
  1117. Effective Component Selection of Atraotydin extract against Influenza virus [J]
  1118. Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products
  1119. Effectiveness of periodic treatment of quercetin against influenza A virus H1N1 through modulation of protein expression
  1120. Effects analysis of antiherpes simplex virus type-1 with combination of Rhizoma polygoni cusp idati and Lonicerahypoglauca Miq [J]
  1121. Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials
  1122. Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase
  1123. Effects of Clinacanthus siamensis leaf extract on influenza virus infection
  1124. Effects of dietary soy isoflavone s and soy protein source on response of weanling pigs to porcine reproductive and respiratory syndrome viral infection
  1125. Effects of different principles of traditional Chinese medicine treatment on TLR7/NF-ÎșB signaling pathway in influenza virus infected mice
  1126. Effects of Esberitox N on viral Titer of Salivary Gland in Cytomegalovirus -Infected Mice [J]
  1127. Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A
  1128. Effects of Gryllus bimaculatus (Gb) fractions on viral hepatitis
  1129. Effects of Hepatitis B virus X protein on the expression of interferon-induced MxA protein [J]
  1130. Effects of hop water extract s on hemagglutination reaction of influenza A virus and influenza A virus -induced mortality in mice
  1131. Effects of Ilex paraguariensis A. St. Hil. (Yerba Mate) on Herpes Simplex virus Types 1 and 2 Replication
  1132. Effects of interferon and Astragalus membranaceus (Huangqi) on TNF-α expression in murine viral myocarditis [J]
  1133. Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled 

  1134. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication
  1135. Effects of Phyllanthus plant extract s on duck hepatitis B virus in vitro and in vivo
  1136. Effects of Phyllathus Amarus on Hepatitis B virus
  1137. Effects of plastic screens on virus infection, yield and qualitative characteristics of small tomatoes
  1138. Effects of propolis FLAVONOIDS on virus infectivity and replication.
  1139. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection
  1140. Effects of Shenqi Fuzheng injection on Fas/FasL protein expression levels in the cardiomyocytes of a mouse model of viral myocarditis
  1141. Effects of silymarin on hepatitis C virus and haem oxygenase‐1 gene expression in human hepatoma cells
  1142. Effects of silymarin supplementation in patients with chronic hepatitis C receiving PEG-IFN+ ribavirin antiviral therapy. A placebo-controlled double blind study
  1143. Effects of Sulfated Glucomannan on the antiviral Activity of Broiler Infected with IBDV
  1144. Effects of the combination of baicalin and ribavirin on influenza A virus infection in vitro and in vivo
  1145. Effects of TheraMax on influenza virus infections in cell culture and in mice
  1146. Effects of Total flavone s from Taraxaci Herba on Ardiomyocyte Apoptosis in Mice with viral Myocarditis [J]
  1147. Effects of total flavonids of astragalus on arrhythmia, endoplasmic reticulum stress in mice with viral myocarditis
  1148. Effects of triterpenoids and FLAVONOIDS isolated from Alnus firma on HIV-1 viral enzymes
  1149. Effects of viral replication on cellular membrane metabolism and function
  1150. Effects of Xinjiaxiangruyin on the TLR7 pathway in influenza virus -infected lungs of mice housed in a hygrothermal environment
  1151. Efficacy of Bidens pilosa extract against herpes simplex virus infection in vitro and in vivo
  1152. Efficacy of Brazilian propolis against herpes simplex virus type 1 infection in mice and their modes of antiherpetic efficacies
  1153. Efficacy of Echinacea purpurea and protexin on systemic and mucosal immune response to Newcastle diseases virus vaccination (VG/GA strain) in commercial turkey 

  1154. Efficacy of extract s and iridoid glucosides from Pentas lanceolata on humoral and cell-mediated immune response of viral vaccine
  1155. Efficacy of Garlic and Onion against virus
  1156. Efficacy of hepatoprotective agents with or without antiviral drugs on liver function and fibrosis in patients with hepatitis B: a meta-analysis
  1157. Efficacy of Houttuynia cordata Thunb. extract s Against Herpes Simplex virus Infection
  1158. Efficacy of Korean traditional medicines against influenza virus infection in mice and their modes of anti-influenza virus action
  1159. Efficacy of orally administered Lobelia chinensis extract s on herpes simplex virus type 1 infection in BALB/c mice
  1160. Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis
  1161. Eleusine indica Inhibits Early and Late Phases of Herpes Simplex virus Type 1 Replication Cycle and Reduces Progeny Infectivity
  1162. Emerging therapeutic targets in antiviral and anticancer therapy: a role for ribonucleotide reductase
  1163. Emerging Trends in Non-Interferon-Based Genotype-Specific antiviral Agents: Pharmaceutical Perspectives
  1164. Empirical studies on the extract s from compatibility of Flos Lonicerae and Forsythia suspense inhibiting influenza A virus FM1 strain in vitro [J]
  1165. Empirical study in vitro of inhibiting action of membranaceus component A6 on influenza virus [J]
  1166. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease
  1167. Endonuclease activity inhibition of the NS1 protein of parvovirus B19 as a novel target for antiviral drug development
  1168. Enhancement of in vivo anti-influenza virus activity of 5, 7, 4′-trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose
  1169. Enhancement of the Herpes Simplex virus Thymidine Kinase/Ganciclovir Bystander Effect and Its Antitumor Efficacy In Vivo by Pharmacologic Manipulation of Gap 

  1170. Ent-kaurene Diterpenoids from Sideritis lycia with antiviral and Cytotoxic Activities
  1171. Environmental risk factors for multiple sclerosis. Results from animal and human studies on diet, vitamin D and Epstein-Barr virus
  1172. Enzymatic synthesis of novel phenol acid rutinosides using rutinase and their antiviral activity in vitro
  1173. Epidemiological analysis on viral hepatitis in Hangzhou city Xiacheng county from year 1998 to 2007 [J]
  1174. Epidemiological Investigcation of and Control Strategies for Swine viral Diarrhea [J]
  1175. Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state
  1176. Epimedium koreanum Nakai water extract exhibits antiviral activity against porcine epidermic diarrhea virus in vitro and in vivo
  1177. EPsÂź 7630 (UmckaloaboÂź), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo
  1178. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
  1179. Epstein–Barr virus : diseases linked to infection and transformation
  1180. Ergosterol peroxide suppresses influenza A virus -induced pro-inflammatory response and apoptosis by blocking RIG-I signaling
  1181. Essential oils of aromatic plant s with antifungal, antibacterial, antiviral , and cytotoxic properties–an overview
  1182. Establishment and analysis of the reference sequence of CoxA16 virus prevailing in mainland China
  1183. Establishment of a stable cell line coexpressing dengue virus -2 and green fluorescent protein for screening of antiviral compounds
  1184. Establishment of chicken embryo fibroblast model for ginsenoside with molecular modification against Marek’s disease virus in vitro
  1185. Establishment of Simple Cell-based Screening Assay and the Identification of Potent antiviral Activity of a plant extract against HSV-1
  1186. Ethanol extract and chromatographic fractions of Tamarindus indica stem bark inhibits Newcastle disease virus replication
  1187. Ethanol extract from Ampelopsis sinica root exerts anti-hepatitis B virus activity via inhibition of p53 pathway in vitro
  1188. Ethanol extract s of Cassia grandis and Tabernaemontana cymosa inhibit the in vitro replication of dengue virus serotype 2
  1189. Ethnobotanical survey of some cameroonian plant s used for the treatment of viral disease
  1190. Ethnomedicinal Wisdom: An Approach for antiviral Drug Development
  1191. Ethnomedicines in antiviral Drug Discovery
  1192. Etiology of Chronic Disease: A Discussion on Ep-stein-Barr virus
  1193. Eupafolin and ethyl acetate fraction of Kalanchoe gracilis stem extract show potent antiviral activities against enterovirus 71 and coxsackievirus A16
  1194. Eupatorium fortunei and its components increase antiviral immune responses against RNA virus es
  1195. Evaluating the efficacy of Achillea millefolium and Thymus vulgaris extract s against Newcastle disease virus in Ovo
  1196. Evaluation of active fraction from plant extract s of Alstonia scholaris for its in–vitro and in–vivo antiviral activity
  1197. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus -related pulmonary tuberculosis
  1198. Evaluation of anti-viral activity of Jatropha curcas leaf extract s against potentially drug-resistant HIV isolates
  1199. Evaluation of anti‐infective potential of a tribal folklore Odina wodier Roxb against some selected microbes and herpes simplex virus associated with skin infection
  1200. Evaluation of antibacterial, antifungal, antiviral , and antioxidant potentials of some edible oils and their fatty acid profiles
  1201. EVALUATION OF antiviral ACTIVITIES OF DIFFERENT TYPES OF PROPOLIS extract S
  1202. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract , quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
  1203. Evaluation of antiviral activity of aqueous extract s from Achyrocline satureioides against Western equine encephalitis virus
  1204. Evaluation of antiviral activity of Azadirachta indica (Neem) bark extract against Newcastle disease virus
  1205. Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus
  1206. Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extract s against H9N2 virus using embryonated chicken egg model
  1207. Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus
  1208. Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus
  1209. Evaluation of antiviral activity of South American plant extract s against herpes simplex virus type 1 and rabies virus
  1210. Evaluation of antiviral and Antimicrobial Activities of Ribes Species Growing in Turkey
  1211. Evaluation of antiviral and Antioxidant Activity of Selected herbal extract s
  1212. Evaluation of antiviral and cytotoxic activities of methanolic extract of S. grandiflora (Fabaceae) flowers
  1213. Evaluation of antiviral and Cytotoxic Activities of Methanolic extract of Thespesia Populnea (Malvaceae) Flowers
  1214. Evaluation of antiviral effect and toxicity of total FLAVONOIDS extract ed from Robinia pseudoacacia cv. idaho
  1215. Evaluation of antiviral effect of Epigallocatechin gallate, Epigallocatechin, Epicatechin gallate and green tea extract against fowl Adenovirus -4
  1216. Evaluation of antiviral Effect of Rutagraveolens extract on Herpes Simplex virus Type 1 in Human Cell Line
  1217. Evaluation of antiviral potential of different Cholistani plant s against infectious bursal disease and infectious bronchitis virus
  1218. Evaluation of antiviral principles for the induction of systemic resistance in blackgram (Vigna mungo) against Urdbean Leaf Crinkle virus
  1219. Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus .
  1220. Evaluation of cytotoxicity, anti-herpes simplex virus type 1 (HSV-1) and antibacterial activities of Ficus vasta and phytoconstituents
  1221. Evaluation of direct antiviral activity of the Deva-5 herb formulation and extract s of five Asian plant s against influenza A virus H3N8
  1222. Evaluation of immune Boosting Properties and Combating of Multiple Respiratory viral Infections by fifteen Euphorbiaceae plant extract s
  1223. Evaluation of in Vitro antiviral Activity of Centaurea Kotschyi var. Decumbens extract s Against Herpes Simplex virus Type 1 (HSV-1)
  1224. Evaluation of in vitro antiviral activity of Vitex Negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to Chikungunya virus
  1225. Evaluation of in vitro antiviral activity of Vitex Negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to Chikungunya virus
  1226. Evaluation of Jatropha curcas Linn. leaf extract s for its cytotoxicity and potential to inhibit hemagglutinin protein of influenza virus
  1227. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase
  1228. Evaluation of phytoconstituents and molecular docking against NS3 protease of hepatitis C virus
  1229. Evaluation of plant extract s: Artemisia afra and Annona muricata for inhibitory activities against Mycobacterium tuberculosis and Human immunodeficiency virus
  1230. EVALUATION OF POTENTIAL antiviral ACTIVITY OF THE HYDROALCOHOLIC extract OF LEMON BALM L. AGAINST HERPES SIMPLEX virus TYPE 1
  1231. Evaluation of protective effect of Erythrina variegata and Spondias pinnata in cadmium intoxicated rats and their antiviral activity against PPR and CSF virus in 

  1232. Evaluation of the activity of Tontelea micrantha extract s against Bacteria, Candida and Mayaro virus .
  1233. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory 

  1234. Evaluation of the antioxidant and antiviral actions of herbal preparations: Rovital and Carciverin V (C1983)
  1235. Evaluation of the antiviral activities of Bacharis dracunculifolia and quercetin on Equid herpesvirus 1 in a murine model
  1236. EVALUATION OF THE antiviral ACTIVITY OF Ballota glandulosissima Hub.-Mor. & Patzak extract S AGAINST RESPIRATORY SYNCYTIAL virus 

  1237. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus
  1238. Evaluation of the antiviral activity of sage leaves (Salvia officinalis) extract against foot-and-mouth disease virus .
  1239. Evaluation of the antiviral effects of aqueous extract s of red and yellow onions (Allium Cepa) against avian influenza virus subtype H9N2
  1240. Evaluation of the antiviral Potential of Halogenated DihydrorugosaFLAVONOIDS and Molecular Modeling with nsP3 Protein of Chikungunya virus (CHIKV)
  1241. Evaluation of the role of the antioxidant silymarin in modulating the in vivo genotoxicity of the antiviral drug ribavirin in mice
  1242. Evaluation of the Sensitivity of Measles virus and Herpes Simplex virus -1 to Three Locally Available Herbs in Nigeria
  1243. Evaluation of the use of different solvents to extract the four main components of Yinqiaosan and their in vitro inhibitory effects on influenza-A virus
  1244. Evaluation of the virucidal efficacy of commercial antiviral drugs against Lasota virus a surrogate for enveloped virus es
  1245. Evaluation on anti-hepatitis viral activity of Vitis vinifer L
  1246. Evans blue inhibits HBV replication through a dual antiviral mechanism by targeting virus binding and capsid assembly
  1247. Evidence for clinical use of honey in wound healing as an anti-bacterial, anti-inflammatory anti-oxidant and anti-viral agent: A review
  1248. Evodia rutaecarpa and three major alkaloids abrogate influenza A virus (H1N1)-induced chemokines production and cell migration
  1249. Evolution of new variants/mutants of JE virus , its effect on neurovirulence, antigenicity, host immune responses and disease transmission in endemic areas
  1250. Examining dioxin-mediated alterations in pulmonary immune cell function during influenza virus infection: effects on cytolytic activity and interferon gamma
  1251. Experimental studies on inhibitory effects of total FLAVONOIDS in Scorzonera austriaca Wild on hepatitis B virus in vitro
  1252. Experimental study of the effect of water extract s from Helicteres angustifolia on anti-hepatitis B virus and protecting hepatocyte activity in vitro [J]
  1253. Experimental study of water extract from Helicteres Angustifolia on duck Hepatitis B virus in vivo
  1254. Experimental Study on Anti-Duck Hepatitis B viral Effect of Phyllanthus urinaria of Different Areas and Combined Therapy with Other Drugs [J]
  1255. Experimental Study on antiviral Effect of Protoporphyrin Disodium on Duck Hepatitis B virus [J]
  1256. Experimental Study on Effect of Anti-Influenza virus of Shengjiang Powder [J]
  1257. Experimental study on effect of chlorophyll-carotene ointment from pine needles against influenza A virus in vitro [J]
  1258. Experimental Study on Effect of Different Radix extract s on Anti-Influenza virus A
  1259. Experimental study on effect of maxing shigan decoction on anti-influenza virus A in vitro
  1260. Experimental study on guanzhong anti-influenza a virus FM1 strain
  1261. Experimental Study on Influence of Embryo-Bud Nourishing Capsule on serum IL-2 and TNF-α in Mice with Influenza virus Infection [J]
  1262. Experimental Study on Kegan Compound Inhibit Influenza virus Infection
  1263. Experimental study on the action of Yinqiaosan against Influenza virus A_1.[J]
  1264. Exploration of (hetero) aryl Derived Thienylchalcones for antiviral and Anticancer Activities
  1265. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection
  1266. Exploring FLAVONOIDS for the Inhibition of Hepatitis C virus by Targeting NS3 Protease
  1267. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
  1268. Expression and identification of Nucleoprotein (NP) of Influenza A virus and Prediction B cell epitopes at NP
  1269. Expressional screening of interferon‐stimulated genes for antiviral activity against hepatitis C virus replication
  1270. Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch
  1271. extract from Aphloia theiformis, an edible indigenous plant from Reunion Island, impairs Zika virus attachment to the host cell surface
  1272. extract of Scutellaria baicalensis inhibits dengue virus replication
  1273. extract ion of Chlorogenic Acid from Chinese herbal Medicine and its antiviral Effect on Porcine Parvovirus in Vitro
  1274. extract ion of Total Lignans from Radix Isatidis and Its Ant-RSV virus Effect
  1275. extract ion of total lignans from radix isatidis and its antiviral activity
  1276. extract ion of Volatile Oil from Houttuynia Cordata and Its Anti-biotic and Anti-virus Activities [J]
  1277. extract s and Constituents of Hypericum Perforatum Inhibit the Binding of Various Ligands to Recombinant Receptors Expressed with the Semliki Forest virus System
  1278. extract s from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat
  1279. extract s of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2
  1280. extract s of Moringa oleifera Lam. showing inhibitory activity against early steps in the infectivity of HIV-1 lentiviral particles in a viral vector-based screening
  1281. Ficus religiosa L. bark %3

Related Posts

Shopping Cart
Scroll to Top